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1 Abstract 
 
Arabidopsis thaliana Carotenoid Cleavage Dioxygenase 1 (AtCCD1) is the role model for 
CCDs, a class of enzymes that cleave highly specific C=C double bonds in carotenoids and 
apo-carotenoids. CCD1s cleave carotenoids symmetrically and regio-selective at the 9-10 
and 9’-10’ position. The active site of CCDs contains a central, heme-free Fe2+, which is 
coordinated by four histidines. The enzymatic oxidation utilizes molecular oxygen and does 
not require further cofactors. This unique cleavage step is used in nature to create a huge 
variety of colorants, flavors and fragrances. It occurs in all branches of life from protozoa, 
metazoa to plants and fungi. In vitro, organic solvents show an activation effect towards 
CCD1 cleavage. The understanding of this mechanism has not been resolved up till now. 
Vast numbers of cleaved carotenoids show a complex chemistry and cannot be synthetized 
by chemical methods. Utilization of carotenoids as substrates to produce apo-carotenoids is 
a promising and novel approach. However, recombinant expression of AtCCD1 occurs 
predominantly as inclusion bodies and thus low enzymatic activity is achieved. CCD1 can be 
refolded from inclusion bodies, or purified by N- and C-terminal tags. Both methods yield a 
modified or tagged enzyme, and are limited in their application to characterize CCDs. 
 
A tag-free purification protocol was developed and permits investigation of the native 
AtCCD1 in vitro. High throughput screening (HTS) of AtCCD1 was possible by establishing 
the expression in a 96 well micro-titer-plate (MTP) format. The activity and stability of 
AtCCD1 with organic co-solvents was of special interest because it aided solubility 
characteristics of the hydrophobic carotenoids. In addition, the conversion of different 
carotenoid substrates was of key interest because of the regio-specificityof the cleavage 
reaction. Four complimentary mutagenesis methods were used to generate libraries of 
AtCCD1 in iterative rounds of directed evolution. Development of recombinant MTP 
expression in combination with novel HTS methods allowed; (I) screening conversion of 
carotenoids by substrate depletion, (II) fluorescence of the central cleavage product of 
carotenoids, (III) the conversion of apo-8’-retinal in the presence of organic co-solvents. The 
methods were applied to evolve AtCCD1 towards; (a) stability in the presence of organic 
solvents and (b) conversion of carotenoids. Several key-residues for AtCCD1 were 
determined, including serine 363, which is involved in substrate determination. 
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2 Introduction 
2.1 Carotenoids 
β-carotene and its derivates belong to the isoprenoids or terpenes, one of the most diverse 
groups of compounds synthesized by biological systems. It has been estimated that there 
are approximately 50,000 known isoprenoids, which include the sterols and carotenoids1. 
Isoprenoids are important in maintaining membrane fluidity, electron transport, protein 
prenylation, cellular and organism development. They are also used as fragrances and 
essential oils as well as antibacterial and antifungal agents2. Terpenes are classified by the 
number of isoprene (C5) units they are composed of. Monoterpenes (C10), such as menthol 
and camphor, and sesquiterpenes (C15), such as zingiberene (ginger), are the major 
constituents of herbs and spices. Higher molecular weight terpenes stabilize membranes 
(cholesterol and C30 composites) or serve as photoreceptive agents (carotenoids and other 
C40 compounds). Alternatively they are further utilized by catabolic enzymes such as 
Carotenoid Cleavage dioxygenases (CCDs)A. A challenge in using carotenoids as substrate 
is their strong hydrophobicity and insolubility in water3,4. 
 
2.2 Carotenoid Cleaveage Dioxygenases (CCDs) 
CCDs are enzymes that cleave highly specific C=C double bonds in terpenes. All CCDs 
exhibit highly conserved regions and, to current knowledge, share a similar structure setup. 
They differ from classical “non-heme iron dependent oxygenases”, which are responsible for 
aromatic degradation in bacteria5,6, by the setup of their active site. In CCDs the active site 
contains a central Fe2+ coordinated by four histidines. The oxidation step utilizes molecular 
oxygen, occurs at room temperature and does not require further cofactors distinguishing 
CCDs from other oxygenases that require a set of cofactors to regenerate their redox 
potential7 (e.g. P450-oxidases or glucose oxidase).  
 
CCDs have been isolated mostly from plants8-12, cyanobacteria13,14, animals15-17 and fungi18. 
CCDs utilize carotenoids which are synthesized in the organism via the dxp- or mevalonate-
pathway. Nonetheless, also organisms have been reported to harbor genes coding for 
CCDs, which cannot synthesize terpenes. Most CCDs are membrane associated, only some 
are reported to be located in the cytosol19,20. The function of apo-carotenoids produced by 
                                               
A
 CCD = carotenoid cleavage dioxygenase 
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CCDs is understood only in few cases21,22, a very well-investigated example is the synthesis 
of retinal23 in the retina which is mandatory for vision in animals. In plants an important 
function is the synthesis of the diverse signal molecule abscisic acid24 (ABAB) and further 
production of “plant hormones”25,26. Cleavage products of CCDs have been shown to play an 
important role in plant growth, protection against light exposure27, as anti-fungal agents and 
as source of fragrances28 for reproduction. 
History 
In vivo production of vitamin A via the β-carotene pathway was first published in 193029. In 
1965, two research groups showed independently that β-carotene is cleaved when treated 
with crude cell-lysate from rat intestines or liver30,31. However, it took until 1997 before VP14 
was isolated10. Viviparous maize seedlings, a phenotype related to a lack of ABA showed 
deficiency in a new and hitherto unknown gene10. ABA was postulated to be derived from 
carotenoids via cleavage, and enzymatic analysis of recombinant VP14 confirmed that it 
indeed cleaves 9-cis-epoxy-carotenoids to 
form ABA. In the following years, 
homologous gene sequences were named 
9-cis-epoxycarotenoid-dioxygenase-like 
(NCED-like) genes. In 2001, the first 
dioxygenase was characterized catalyzing 
the long ago described β-carotene 
cleavage to vitamin A32. The assumed 
double-oxidation mechanism led to the 
term carotenoid-cleavage-dioxygenase 
(CCD). Cleavage of CCDs is highly 
regiospecific, nevertheless, in vitro, several 
carotenoid substrates are utilized22. In vivo 
the required specificity is probably 
regulated by the limited variety of 
carotenoids available to the enzyme. 
Plant CCDs are clustered into three 
classes, based on their phylogenetic origin 
(Figure 1) and reassembling their cleavage 
pattern8. 
 
                                               
B
 ABA = abscisic acid, growth hormone that regulates vertical growth in plants 
 
Figure 1: Phylogenetic tree of known CCDs
8
. Most plant CCDs 
are grouped by substrate and cleavage mechanism, NCED 
cleavage (classI), symmetric 9-10 and 9’-10’ cleavage by CCD1-
like enzymes (class II) and shorter CCDs (class III). The new 
described AtCCDs 7 and 8 differ most from the known plant 
CCDs. “Syn2”, is the 15-15’ CCD crystalized in 2006.  
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Crystallization of a retinal 
forming carotenoid oxygenase33 
in 2005 opened first insight into 
the molecule and proved that 
the active site contains a Fe2+, 
which is coordinated by four 
histidines. It was also observed, 
that the substrate (apo-8’-
retinalC) is changed from its all-
trans to a 13-14 and 13’-14’-cis conformation flanking the actual cleavage site 15-15’ (Figure 
2). 
Ongoing research on CCDs 
CCDs are globular proteins comprising of one folding domain, which consists mainly of a 7-
bladed propeller formed by antiparallel β-sheets, and a “dome” domain (Figure 2). The N-
terminus appears heterogeneous and diverse among different CCDs. In 2009, RPE65D from 
bovine was crystallized34, a related but rather distant mammalian isomerase. RPE65 is 
crucial in the retina and shows cleavage and isomerization of all-trans-retinyl fatty acid esters 
to 11-cis-retinol. In 2010 a model of RPE65 that may represent its working environment as 
membrane associated enzyme was published. The structure and functional homologies to 
CCDs may help to understand how CCDs interact with membranes. In general, conservation 
is rather low with ~40-60% identities on the amino acid level. No disulfide bounds have been 
reported from any CCD. 
CCD1 
CCD1s are the most frequently investigated and therefore best-characterized group of CCDs 
in plants and fungi. They differ in their cellular localization as they are located in the cytosol 
whereas all other plant CCDs are located in plastids. CCD1s have been shown to cleave a 
large spectrum of carotenoids and apocarotenoids in vitro11,35,36, however recent experiments 
with interference RNA (RNAi) suggest that the in vivo substrate is a C27 apocarotenoid – at 
least in Medicago truncatula37. According to these conclusions, the first CCD in carotenoid 
cleavage might be CCD7, followed by CCD1. From all plant and fungal CCDs, Arabidopsis 
                                               
C
 apo-8’-retinal =  apo-carotenoid derived from 7’-8’ cleavage of β-carotene 
D
 RPE = retinal pigment epithelium specific, 65kDa protein 
 
Figure 2: Scheme of Aco1
7
. The iron is hold in the center of the cleavage 
site; the substrate channel separates the enzyme body from the “dome”, 
which forms a lid. The patch is used to attach the enzyme to the 
membrane. 
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thaliana CCD1 (AtCCD1) has a model role and is the most studied CCD. The knowledge 
about AtCCD1, its cleavage reaction and the ability to express it recombinant in E. coli were 
the main criteria for selecting it in this study. 
2.2.1 Mechanism 
Following the Aco1 crystal structure and 
further experiments11,38, two reaction 
mechanisms7 have been developed for 
CCDs which are summarized in Figure 3. 
The oxygen (molecular oxygen dissolved in 
the aqueous environment) binds to the Fe2+ 
and the substrate, creating a peroxide-
intermediate. Afterwards, either a di-
oxygenase mechanism oxidizes the double 
bond simultaneously on both carbons as it 
has been proposed for AtCCD138; 
alternatively two consecutive oxidation 
steps, including the formation of an epoxy-
intermediate, may lead to formation of two 
carbonyls, as it has been proposed for 
NOV239. The central cleavage of β-carotene 
in eukaryotes has been described to follow 
the mono-oxygenase mechanism,  e.g. for 
chicken β-carotene- 15,15’-oxygenase40, 
whereas a bacterial Blh-protein (β-carotene- 
15,15’-oxygenase) is reported to use only the di-oxygenase mechanism41. All studies used 
radioactively labeled oxygen to determine the mechanism, however the outcome of these 
experiments have been interpreted in different means, as an exchange of labeled 18O with 
the 16O, especially in carbonyl- or aldehyde groups cannot be excluded. A recent study using 
density functional calculations (DFT)42 suggested that, in the case of Aco1, the dioxetane 
mechanism is slightly favored over the epoxide intermediate – however both mechanism are 
possible. A final conclusion of the reaction mechanism cannot be drawn and both reaction 
pathways may occur in parallel – possibly even within one enzyme.  
 
Most putative carotenoid cleavage enzymes have been termed dioxygenases and are 
currently classified as EC 1.13.11 (oxidoreductases; acting on single donors with 
incorporation of molecular oxygen; with incorporation of two atoms of oxygen) The 
“carotenoid cleavage mono-oxygenases” (CCO)43 are classified under EC 1.14.99 
 
Figure 3: Proposed mono- or di-oxygenase mechanism for 
CCDs. Oxygen introduced from molecular oxygen is 
highlighted in yellow, Oxygen from water in grey. Adapted 
from
7
. 
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(oxidoreductases; acting on paired donors, with incorporation or reduction of molecular 
oxygen; miscellaneous).  For this thesis, the differences of these two mechanisms were not 
investigated.  
 
The term “CCD” is used as superfamily to describe any member of this family, which includes 
CCDs and NCEDs. 
2.3 Enzyme-substrate mediation 
The already mentioned hydrophobicity of the CCD substrates in section 2.1 opens up an 
interesting field of research for enzyme substrate mediation. In vivo, carotenoids can be 
stored and accumulated in the membrane between the lipid bilayers or in plastids44. CCDs 
have been shown to be attached to cell membranes and by this means access their 
corresponding substrates. Unfortunately the system is still not well-understood. In bacteria, 
the subcellular location of carotenoid cleavage is unknown. Possibilities include e.g. transport 
of the carotenoid to the membrane followed by its cleavage, direct conversion after synthesis 
in the cytosol or carotenoid aggregation in the cytosol and subsequent cleavage by CCDs. In 
vitro, the topic of substrate delivery is likewise complex. None of the substrates for AtCCD1 
may be directly dissolved in an aqueous solution. Since 2001, in vitro assays based on 
extracted and purified carotenoids have been known11 and in 2003 a surfactant based in vitro 
assay has been described9. For the latter, the carotenoid substrate is dissolved in an organic 
solvent and a surfactant (Triton X-100, Tween 40E or β–octylglucoside) and the organic 
solvent is removed afterwards either by vacuum or nitrogen stream. The surfactant-substrate 
“paste” can then be dissolved in aqueous buffer, forming micelles. Hydrophobic interactions 
lead to the lipophilic part forming the inside of the micelle and the hydrophilic side being 
exposed to the aqueous liquid. Carotenoids are either trapped inside, or at the interface of 
the micelles, depending on their structural properties. This leads to a solubilization of the 
carotenoids and they can be converted by CCDs. During the last years different solvent, 
surfactant and buffer conditions have been evaluated for AtCCD145,46.  
 
Properties of the micellar assay 
The above described method allows direct determination of AtCCD1 activity for carotenoids 
or apocarotenoids. The apparent homogeneous solutions allow visual control of the cleavage 
process and the reaction can be stopped by breaking the micelles. Substrate concentrations 
                                               
E
 Tween 40 = polyoxyethylene sobitan monopalmitate 
- 7 - 
of up to the 250 µM are achieved; for further analysis, substrate and products can be 
separated using TLCF or HPLCG. 
 
Four inevitable system dependent facts are included in this assay. First, the micelles are a 
dynamic, heterogeneous system if observed on a nanoscopic scale and they are not 
permanently stable. Depending on ionic strength, protein- and substrate-concentration, 
micelles disintegrate after a certain period of time. Second, enzyme performance is 
measured dependent on the micellar delivery system. There are limited possibilities to 
determine how the substrate is actually delivered to the enzyme or if the interface between 
micelles and aqueous phase causes limitations by influencing the interaction with the 
enzyme. The third effect comprises the usage of surfactants itself. The amphipathic 
character that enables dissolving of the substrates also affects the enzyme. To current 
knowledge, Triton X-100 stabilizes AtCCD1 and enables its extraction and purification – 
nevertheless negative effects are possible, e.g. if the surfactants contain peroxides or if their 
overall concentration surpasses a certain threshold. Finally, surfactants and their critical-
micellar-concentration (CMC) are affected by organic solvents, influencing stability and 
absorption coefficient of the micelles. The equilibrium and absorption coefficient are 
disordered by every change in the buffer. In general, substrate delivery remains, even in 
vitro, a black box. 
 
2.4 Industrial applications 
Carotenoids are an attractive resource for the industrial production of bioactive substances, 
such as aroma, food colorants and vitamins including e.g. α- and β-ionone, β-damascenone, 
safranal, retinal and crocetin. Biotechnological production based on natural carotenoid 
sources (e.g. fungi or algae) promises significant productivity boosts and improved cost 
efficiencies compared to the current isolation of natural flavors via extraction and 
distillation47. Moreover, recombinant expression of whole carotenoid synthesis pathways 
followed by cleavage to a final aroma or fragrance is imaginable. Despite the huge amount of 
products, flavors and food colors based on carotenoids, biotechnological production has 
been described only for few biocatalysts on a laboratory scale. Currently used mechanisms 
lack regiospecific oxidation of the substrate and produce a wide range of cleavage 
products48.  
 
                                               
F
 TLC = thin layer chromatography 
G
 HPLC = high performance liquid chromatography 
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The possible in vitro conversion and the unique properties of CCDs make them attractive for 
research on the substrate recognition and delivery procedures as well as for industrial 
applications. The variety of flavors, fragrances and colors created by CCDs is immense, yet 
only partially elucidated. Colors and fragrances in roses have been investigated in detail49 – 
and all of them may be synthesized or affected by CCDs. To current knowledge the ability to 
cleave carotenoids regiospecific is only possible using CCDs. Second, molecular oxygen is 
used for oxidation – the cheapest available oxidant. Third, no cofactors are needed except 
for a central iron that catalyzes the cleavage reaction. So far no industrial application of 
CCDs has been developed, but possible applications are investigated, e.g. bleaching of flour 
or enzymatic conversion of β-carotene to valuable flavors and fragrances. 
 
2.5 Project objectives 
Of special interest was the activity of AtCCD1 with organic solvents as well as the conversion 
of different carotenoid substrates. A selection of organic solvents (ethyl alcohol, 2-propanol, 
THF and DMSO) was investigated and expression downscaled to the micro titer plate format. 
Based on this initial research, ethyl alcohol was chosen as preferred organic solvent, and a 
screening assay for conversion of apo-8’-retinal in the presence of ethyl alcohol and other 
organic solvents established. In sequential rounds of screening, epPCR with different 
unbalanced nucleotides were applied to cover a broad mutation spectra. For a more diverse 
library generation, two SeSaM libraries, which yield transversions- and consecutive 
nucleotide-changes were generated. Positions determined during HTS screening were 
further investigated by site-saturation mutagenesis. Additionally, for validation of the mutants 
determined in HTS, a tag-free purification protocol was developed that allows investigation of 
purified native AtCCD1 in vitro. To engineer AtCCD1 for improved conversion of full length 
carotenoids, β-carotene, zeaxanthin and astaxanthin were investigated leading to zeaxanthin 
being selected as preferred substrate. Two novel HTS methods were developed that allow 
screening for conversion of e.g. zeaxanthin either by substrate depletion or by fluorescence 
of the central cleavage product of carotenoids.  
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3 Materials and methods 
3.1 Vendors of chemicals and instruments 
Alphabetic list of companies: 
 
Applichem GmbH, Darmstadt 
BMG Labtech, Offenburg 
Corning Life Science BV, Amsterdam, Netherlands 
Diversifiedbiotech, Dedham, Massachusetts, USA 
EnzyScreen BV, Al Leiden, Netherlands 
GE-Healthcare Europe GmbH, Munich 
Geneart AG, Regensburg 
Greiner Bio One GmbH, Frickenhausen 
Incutec GmbH, Mössingen  
JASCO Labor- und Datentechnik GmbH, Gross-Umstadt 
Macherey-Nagel GmbH & Co. KG, Düren 
Merck KGaA, Darmstadt 
NEB - New England Biolabs, Frankfurt 
Sigma-Aldrich/ Fluka, Taufkirchen 
Steinbrenner Laborsysteme GmbH, Wiesenbach 
Tecan Deutschland GmbH, Crailsheim 
Tosoh Bioscience GmbH, Stuttgart 
 
All enzymes were obtained from NEB, crystalline zeaxanthin and astaxanthin was a courtesy 
of BASF SE, Ludwigshafen. If not stated otherwise, the vendor company is based in 
Germany. 
 
3.2 CCD1- cloning and expression in E. coli 
For screening and expression E. coli was chosen as host organism, as method required for 
directed evolution are well established, and AtCCD1 has been recombinant expressed in E. 
coli before38. 
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3.2.1 Cloning of AtCCD1 
Construction of pET28a-AtCCD1synv2 
The synthetic gene AtCCD1 [Geneart, 0723598] was amplified with primerI and primerII (see 
section 6.2), using standard PCR protocol and cloned into pET28a(+). For cloning, vector 
and PCR products were digested with NcoI and HindIII [NEB]. The construct was validated 
using plasmid digestion and sequencing. One silent mutation occurred (GAT -> GAC) at 
position 1376, but as enzymatic activity was observed, this version was used for all further 
experiments with AtCCD1. 
Construction of pGex6p4-AtCCD1 
AtCCd1synv2 was amplified using primersIII, IV(see section 6.2) and standard PCR conditions 
to introduce the additional restriction site NcoI. pGex6p1 [GE-Healthcare] and the PCR 
product were digested using BamHI and XhoI [NEB] and ligated, the construct was confirmed 
by restriction digestion and sequencing. PCR, cloning and restriction were performed during 
a lab-rotation by Ranjan Shresta. 
 
Construction of N-terminal deletions 
The N-terminal truncations were generated using a common reverse primerIV and an 
individual forward primerV,VI,VII (see section 6.2) for AtCCD1-Δ16, -Δ39 and -Δ55 respectively. 
Parent was the AtCCd1synv2-pGex6p1 construct, which has a N-terminal GSTH fusion. Due 
to the N-terminal fusion, the first methionine is removed, so the deletions are A2-P16 (-Δ16), 
A2-H39 (-Δ39) and A2-I55 (-Δ55) respectively. 
 
3.2.2 Expression and purification of AtCCD1 
Expression in Erlenmeyer flasks 
The pre-culture was inoculated from a glycerol stock (4 ml MDG50 media, 50 µl/ml 
kanamycin) and incubate overnight at 37 °C, 250 rpm in a test tube. The main-culture 
(2x200 ml LB-media in 1 l non-chicanery flask, 30 µg/ml kanamycin) was inoculated with 
each 0.5 ml of the preculture and grown to OD600 ~0.6 at 37 °C, 250 rpm – which takes 
approx. 2.5 h. The culture was then induced with IPTGI (0.2 mM final concentration) and 
                                               
H
 GST = glutathione-S-transferase 
I
 IPTG = isopropyl-β-D-thiogalactopyranosid 
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further incubated (40 h at 18 °C, 200 rpm). The two flasks were combined in one beaker and 
cells pelletized at 3220 g, 4 °C for 45 min. The supernatant was discarded and the pellet 
frozen at -20 °C and stored or used directly.  
Tag-free purification 
The pellet was resuspended in 40 ml PBSJ by pipetting. The cells were lysed using a high-
pressure-homogenizer “French-press”, two cycles at 1500bar or three cycles at 1000-
1200bar. The suspension was pelletized with a high-speed centrifuge, 16.000 g, 4 °C for 15-
20 min. Afterwards the supernatant was discarded and the pellet resuspended in 40 ml PBS 
by pipetting. The centrifugation step was repeated and the supernatant discarded. The pellet 
was again resuspended in 30 ml PBS with 0.2 % Triton-X-100 [Fluka, 93418] as 
supplementary detergent. The centrifugation was repeated once more and the supernatant 
kept, which contained CCD1 and low amounts of other E. coli proteins. The supernatant was 
concentrated using Amicon Ultra 30kDa [regenerated cellulose 30.000 MWCO, Millipore] to a 
final volume of 1 ml. 
Size-exclusion-chromatography 
For further polishing, CCD1 was loaded on a gel-filtration column (40 cm length, 31.5 ml 
volume, Toyopearl HW-55S [Tosoh Bioscience] resin), with PBS containing 0.02 % Triton X-
100. Protein peaks were observed following optical density at 254 nm (OD254). The purified 
samples were quantified using “Agilent Bioanalyzer 2100” [GE-Healthcare], purities 
exceeding 80 % were achieved for all samples. 
GST-affinity purification for CD 
The protein was expressed as described above, but using the GST-fusion vector (pGex) and 
adequate antibiotic (100 µg/ml ampicillin). Cells were resupended in 100 ml PBS (pH 7.4) 
and lysed with a high-pressure-homogenizer (2 x 1500 bar), then Triton X-100 was added up 
to a final concentration of 0.2 %. The sample was mixed vigorously and centrifuged (4 °C, 
16.000 g, 45 min). The supernatant is retained and passed through 0.45 µM filter; the effluent 
loaded onto a GSTrap HP 5 ml column [GE-Healthcare] and washed with PBS (pH 7.4). The 
sample was eluted with Tris buffer [50 mM Tris, 15 mM glutathione, pH 8.0 at room 
temperature] and “PreScission” [GE Healthcare] protease added and dialysed for 36h at 4°C 
with constant stirring into glutathione free buffer (200 mM NaCl, 25 mM Tris, pH 7.3 at room 
temperature). The sample was again loaded onto the GSTrap HP 5 ml column and the flow-
                                               
J
 PBS = phosphate buffered saline 
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through collected. The sample was concentrated using Amicon Ultra 30 kDa [Millipore] to a 
concentration of 3 mg/ml (determined using OD280) 
CD-spectra recording 
Each sample was prepared, in a PCR tube. The samples consisted of protein solution (20 µl, 
as described above), organic solvent (if used) and dialysis buffer (as above, to 80 µl). For 
blank measurements, only dialysis buffer and organic solvents were added. The tubes were 
incubated at room temperature for 1h then circular-dichroism was recorded within 190-
250 nm in an oxygen free environment using J-810 Spectropolarimeter [JASCO Labor- und 
Datentechnik].  For each condition the blank values were recorded first and then subtracted. 
CD-spectra analysis 
Values returned from the J-810 were transformed into Elliptics according to the formula 
provided with dicroprot51. Protein concentration: 0.75 mg/ml = 1.225x10-5M; amino acids = 
542; milli-degree (MDEG) = 1x10-3 degree; optical length: 0.1 mm = 0.01 cm, resulting in: 
(Elliptics) θ = 1506.138 MDEG.  All files were multiplied with this factor and saved as .dic files 
that can be opened with dicroprot and then deconvoluted using the mentioned algorithm52,53. 
3.2.3 Expression in micro-titer-plates 
Competent cells preparation 
Bl21-Gold(DE3) cells transformed with miniF-plysY plasmid [NEB] were aliquoted and stored 
at -80 °C until usage. One aliquot at a time was thawed on ice and plated on an LB-agar 
plate (20 µg/ml Chloramphenicol) and incubated (16 h, 37 °C). After incubation 15 ml of LB 
media (without antibiotics) were inoculated and grown to OD600 0.6-0.7 and harvested by 
centrifugation (4 °C, 1000 g, 2 min). The pellet was washed on ice with 1 ml glycerol solution 
(15 % glycerol in sterile, deionized water) and the cells again centrifuged (4 °C, 1000 g, 2 
min). Washing was repeated 2-3 times and finally the cells resuspended in 500-1000 µl 
glycerol solution (as described above), aliquoted on ice and used for transformation. 
Libraries 
After transformation, plating on selective plates (50 µg/ml Kanamycin) and incubation (16 h, 
37 °C), colonies were picked in v-bottom MTPsK [”Costar”, Corning Life Science] and grown 
in 100 µl MDG media50 (50 µg/ml Kanamycin, 20 µg/ml Chloramphenicol, 10 h, 37 °C, 900 
rpm, 70 % humidity) under non-inducing conditions. The plates were then transferred to 
inducing conditions using a 96 well cryo-replicator [EnzyScreen]. Expression occurred in v-
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bottom MTPs  [”Costar”, Corning Life Science] and 150 µl LB-media (30 µg/ml Kanamycin, 
20 µg/ml chloramphenicol, 0.2 mM IPTG) for 16 h (25 °C, 700rpm). Cells were harvested by 
centrifugation (5 min, 3220 g, 12 °C), the supernatant discarded and the pellets frozen (-
20 °C) until usage. 
3.3 Assays used for screening 
Figure 4 shows the spectra of the assay 
solution before and after the complete 
conversion by AtCCD1. The change of color 
during this reaction enables a direct 
calculation of the enzymatic activity 
depending on the converted substrate. 
Apo-8’-retinal-substrate solution 
2-5 mg of apo-8’-retinal were aliquoted into 
brown vial and frozen until usage. When 
used, they were resuspended in 50 % (v/v) 
THFL [Sigma, 34865 – inhibitor free] and 50 
% (w/v) Triton X-100 [Fluka, 93418] to a 
final concentration of 2.8 mg/ml apo-8’-retinal. The mixture was diluted in PBS to a final 
concentration of 280 µg/ml apo-8’-retinal and sodium-ascorbate (1 M, pH ~7.5) added to a 
final concentration of 2.5 mM. 
Apo-8’-retinal and ethanol (0-22 %) 
The frozen pellets from MTPs were resuspended in 100 µl PBS (pH 7.3, with 1.5 mg/ml 
lysozyme [Applichem, A3711) by pipetting [Liquidator, Steinbrenner Laborsysteme] and 
incubated for 1.5 h at 30 °C. 20 µl of PBS (pH 7.3, +1.2 % (w/v) Triton X-100) were added to 
each well and vigorously shaken for 5min (1300 rpm) [IH-S, Incutec], the MTP was then 
centrifuged for 20min (12 °C, 3200 g). The supernatant (100 µl final volume) was transferred 
to a fresh 96 well plate [Greiner Bio One, flat bottom] and 1 µl catalase (2.5 mg/ml = 10.000 
U/ml, [Sigma C9322]), 0-22 µl ethanol [Applichem, A2795] added. To start the assay, 10 µl of 
apo-8’-retinal substrate solution was added and shaken for 2 min (500 rpm) [Omega, BMG 
Labtech] before measuring. 
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Figure 4: Spectra of the control reaction (blue, solid, 
pET28a) and complete conversion (black, dashed, 
AtCCD1).  
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Apo-8’-retinal pre-incubation (above 25 % ethanol) 
The frozen pellets from MTPs were resuspended in 100 µl PBS (pH 7.3, with 1.5 mg/ml 
lysozyme [Applichem, A3711) by pipetting [Liquidator, Steinbrenner Laborsysteme] and 
incubated for 1.5 h at 30 °C. 20 µl of PBS (pH 7.3, +1.2 % (w/v) Triton X-100) were added to 
each well and vigorously shaken for 5 min (1300 rpm) [IH-S, Incutec ]. Organic solvent was 
added to the desired concentration (e.g. 30 %, 60 µl in 180 µl total volume), mixed for 2 min 
(500rpm) [Omega, BMG Labtech], the plate removed and sealed [Breathe-Easy, 
Diversifiedbiotech] to control evaporation and incubated for 45 min (30 °C). After incubation 
the samples were diluted with 74 µl PBS (to ~22.6 % ethanol) and centrifuged for 20 min 
(12°C, 3200 g). 89 µl of the supernatant were transferred to 96 well MTP [Greiner Bio One, 
flat bottom], 1 µl of catalase (2.5 mg/ml = 10.000 U/ml, [Sigma C9322]) and 10 µl of substrate 
solution added to start the assay. 
Apo-8’-retinal and 32 % (v/v) DMSO 
The frozen pellets from MTPs were resuspended in 100 µl PBS (pH 7.3, with 1.5 mg/ml 
lysozyme [Applichem, A3711] by pipetting [Liquidator, Steinbrenner Laborsysteme] and 
incubated for 1.5 h at 30 °C. 20µl of PBS (pH 7.3, +1.2 % (w/v) Triton X-100) were added to 
each well and vigorously shaken for 5 min (1300 rpm) [IH-S, Incutec], the MTP was then 
centrifuged for 20 min (12 °C, 3200 g). The supernatant (100 µl final volume) was transferred 
to a fresh 96 well plate [Greiner Bio One, flat bottom] and 32 µl DMSOM [Sigma-Aldrich, 
41640] and 10 µl of apo-8’-retinal substrate solution added to start the assay. Before the 
measurements were taken, the plate was shaken for 2 min (500 rpm) [Omega Spectrostar, 
BMG Labtech]. 
Zeaxanthin stock solution 
Zeaxanthin was dissolved in 50 % (v/v) THF and 50 % (w/v, preheated to 42 °C) Tween 40 
[Sigma P1504 or Merck 822185.0500], to a concentration of 2 mg/ml. First the THF then 
preheated Tween 40 was added. The solution was mixed to homogeneity and diluted with 
875 µl PBS, 25 µl Na-Ascorbat (1 M, pH 7) and 100 µl of the zeaxanthin solution to 1000 µl. 
Zeaxanthin fluorescence assay 
The frozen pellets from MTPs were resuspended in 100 µl PBS (pH 7.3, with 1.5 mg/ml 
lysozyme [Applichem, A3711] by pipetting [Liquidator, Steinbrenner Laborsysteme] and 
incubated for 1.5 h at 30 °C. 20 µl of PBS (pH 7.3, +1.2 % (w/v) Triton X-100) were added to 
each well and vigorously shaken for 5 min (1300 rpm) [IH-S, Incutec], the MTP was then 
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centrifuged for 20 min (12 °C, 3200 g). The supernatant (100 µl final volume) was transferred 
to a fresh 96 well plate [Greiner Bio One, flat bottom] and 10 µl of zeaxanthin substrate 
solution added and briefly mixed by shaking. Blank values were recorded after 2 h, the signal 
recorded after 5-12 h. In between the plate was covered with a lid and parafilm and 
incubated at 30 °C. Fluorescence was recorded on a Safire [Tecan] with following settings: 
excitation: 365 nm, emission: 500 nm, 20 flashes, gain 100, height: 4800 µM, slit: 5 nm each 
Zeaxanthin OD assay 
The frozen pellets from MTPs were resuspended in 100 µl PBS (pH 7.3, with 1.5 mg/ml 
lysozyme [Applichem, A3711] by pipetting [Liquidator, Steinbrenner Laborsysteme] and 
incubated for 1.5 h at 30 °C. 20 µl of PBS (pH 7.3, +1.2 % (w/v) Triton X-100) were added to 
each well and vigorously shaken for 5 min (1300 rpm) [IH-S, Incutec], the MTP was then 
centrifuged for 20 min (12 °C, 3200 g). The supernatant (100 µl final volume) was transferred 
to a fresh 96 well plate [Greiner Bio One, flat bottom] and 10 µl of zeaxanthin substrate 
solution added and briefly mixed by shaking. OD462, and OD600, were monitored [Omega 
Spectrostar, BMG Labtech] and the most active clones selected according to OD462-OD600 
within the first 2 hours. 
TLC robot setup (zeaxanthin fluorescence)  
Samples are prepared as described above (zeaxanthin fluorescence assay), the 96 well 
plate is placed in the robot [ATS4, CAMAG] and spotted directly out of the wells on TLC-
plates [DC Kieselgel 60 RP-18 F254S 10x10 cm aluminiumfoil, Merck]. Spotting (width: 8 mm, 
offset: y= 5 mm, x= 10 mm, spacing: auto, speed: 50-100 nl/sec, nozzle temperature: 40 °C). 
Plates were developed using [ADC2, CAMAG] (solvent: 2 ml H20 + 8 ml ethanol, developing 
height: 70mm, saturation solvent: none, predrying: no, postdrying: 3 min) and analyzed with 
[TLC-Scanner 3, CAMAG] (measurement: absorption, single-wavelength scan: 366 nm, peak 
assignment: manual, peak analysis: 300 nm – 600 nm). 
3.4 Generation of diversity 
In MTP glycerol stocks, controls are highlighted in black (positive) and red (negative), if not 
indicated otherwise, following wells were used for positive- (H1, E7, A12) and negative- (A1, 
E6, H12) controls. Rescreens of libraries have the full clone-name indicated on the original 
lid and a copy can be found in the labbook. 
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3.4.1 Error prone PCR – ep-PCR 
Determination of mutational load 
The concentration of MnCl2 is used to tune the mutagenic frequency to 50 % active vs. 
inactive clones. 
 
Table 1: Determination of active CCD1 clones depending on the MnCl2 concentration used during mutagenesis. 
 
MnCl2 concentration active clones relative activity 
No MnCl2 38 of 40 95% active 
0.01mM MnCl2 73 of 88 83% active 
0.05mM MnCl2 20 of 31 65% active 
0.10mM MnCl2 40 of 75 53% active 
 
100 µM MnCl2 was used for both ep-PCR methods, the ratio shown above was determined 
using method G>>ACT. 
ep-PCR methods applied 
A MAP54 analysis of the synthetic gene AtCCD1v2 was performed and two different  methods 
selected. Method G>>ACT (GTP= 0.4 mM; ATP, CTP, TTP= 0.2 mM) is characterized by: 
low number of stop-codons, high average amino acid substitution, intermediated rate of 
preserved amino acids and a high ration of proline/glycine substitutions. 
Method C=T, G=A (CTP, TTP = 1mM; ATP, GTP= 0.2mM) is characterized by: a high ratio of 
introduced stop codons, a low ratio of proline/glycine substitutions, lower ratio of preserved 
amino acids and an more evenly distributed mutation rate (low codon diversity coefficient). 
The two different methods were used subsequently and are expected to complement each 
other creating higher diversity than may be achieved with only one method applied iteratively.  
ep-library round 1 
Template: AtCCD1synv2; mutagenesis: 100 µM MnCl2, method: G>>ACT,  25 cycles in a 
thermocycler using Taq-Polymerase; cloning with Megawhoop55-PCR: 1000 ng of spin-
column [Nucleospin-II, Macherey-Nagel] purified megaprimers, 55 °C annealing temperature, 
25 cycles in a thermocycler using PfuS. Flanking primers for mutagenesis were F1VIII and 
R3IX – including the promoter- and terminator-region in the mutagenesis.  
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ep-library round 2 
Conditions as described above (ep-library round 1) if not stated otherwise;  template: 
AtCCD1synv2, S363G-AtCCD1, I10V-AtCCD;  cloning: Megawhoop55 with annealing 
temperature: 55 °C – 65 °C (gradient) 
ep-library round 3 
Conditions as described above (ep-library round 1) if not stated otherwise; template: 
AtCCD1synv2, S363G-AtCCD1, I10V-AtCCD1, I10V-S24G-S363G-AtCCD1, S363G-Q539-
AtCCD1; mutagenesis: 100 µM MnCl2, method: C=T, G=A; 25 cycles in a thermocycler using 
Taq-Polymerase. Megawhoop annealing temperature: 58 °C – 63 °C (gradient). 
 
3.4.2 Sequence saturation mutagenesis (SeSaM) 
Two different approaches for SeSaM were applied.  
SeSaM recombinatorial mutagenesis (library 4) 
Handbook Revision: 0.16; Primer: F1VIII and R3IX were used (See section 6.2). The dNTPαs
56 
concentration was determined following the “experimental determination of optimal 
phosphorothioate percentage”. Determined concentration was: 34% dATPαs forward, 33% 
dGTPαs forward, 30% dATPαs reverse and 30% GTPαs reverse. Yields after step 1A: AF 
library: 98 ng/µl, AR library: 124 ng/µl, GF library: 98 ng/µl, GR library: 123ng/µl; Yields after 
step 1B: AF 15,5 ng/µl, AR 31,5 ng/µl, GF 11,3 ng/µl, GR 26,4 ng/µl; Yields after step 2: AF 
9.2 ng/µl, AR 9.3ng/µl, GF 4.7 ng/µl, GR 8.8 ng/µl; Yields after step 3: AF + AR 19 ng/µl, GF 
+ GR 24 ng/µl; Yields after step 4: AF + AR 283 ng/µl, GF + GR 320 ng/µl; Cloning: 
Megawhoop using 1µg of PCR product and 150ng template55. 
SeSaM classic mutagenesis (library 5 +6) 
Primers: F1VIII and R4X (see section 6.2) both extended with the “SeSaM sequence”, for 
template generation F1-upXI and R4-downXII were used (see section 6.2). 
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Table 2: Yields and parent clones of the two classical SeSaM libraries, which were generated in parallel. 
 
 Library 5: SeSaM library 2 
For increased ethanol resistance 
Library 6: SeSaM library 3 
For increase in zeaxanthin conversion 
Parents AtCCD1synv2, I10V-S363G-CCD1, 
S363G-Q539-CCD1,  I10V-S264G-
S363G-CCD1, I10V-S264G-S363G-
L525-CCD1, S363G-T536G-Q539-
CCDC1 
AtCCD1synv2, I10V-CCD1, I10V-
S397G-CCD1, I10V-V194A-CCD1,  
Templates 
 
SeSaM 0: 30 ng/µl, Down: 24 ng/µl, 
Up: 32 ng/µl 
SeSaM 0: 26 ng/µl, Down: 40 ng/µl,  
Up: 30 ng/µl 
SeSaM 1A 
 
AF: 60 ng/µl,  GF: 86 ng/µl, 
AR: 93 ng/µl,  GR: 92 ng/µl  
AF: 151 ng/µl,  GF: 100 ng/µl, 
AR: 134 ng/µl,  GR: 113 ng/µl 
SeSaM 1B 
 
AF: 19 ng/µl,  GF: 24 ng/µl,  
AR: 42 ng/µl,  GR: 33 ng/µl 
AF: 62 ng/µl,  GF: 61 ng/µl,  
AR: 58 ng/µl,  GR: 40 ng/µl 
SeSaM 2 
 
AF: 7.3 ng/µl,  GF: 12.6 ng/µl,  
AR: 14.9 ng/µl,  GR: 6.6 ng/µl 
AF: 7.7 ng/µl,  GF: 31 ng/µl,  
AR: 12.2 ng/µl,  GR: 16.7 ng/µl 
SeSaM 3 
 
AF + GF:  13.9 ng/µl, 
AR + GR:  13.3 ng/µl 
AF: 15.1 ng/µl,  GF: 14.7 ng/µl,  
AR: 19.3 ng/µl,  GR: 13.6 ng/µl 
SeSaM 4 AF + GF:  131 ng/µl, 
AR + GR:  121 ng/µl 
AF: 135 ng/µl,  GF: 127 ng/µl, 
AR: 126 ng/µl,  GR: 119 ng/µl 
Cloning  Restriction with NcoI and HindIII followed by ligation into pET28a. As vector-
backbone, pET28a-CCD7syn was used – not-digested-vectors and WT 
contamination are thereby excluded. 
 
3.4.3 Site saturation mutagenesis 
Site saturation libraries have been generated using an adopted quick-change protocol57 for 
the following positions: I10, V194, S264, S363, S397. NNK primers were used for all 
positions, except 363 where NNN primers were used. Primers: I10XIII + XIV, V194XV + XVI, 
S264XVII + XVIII, S363XIX + XX, S397XXI + XXII (see section 6.2). From each library, two plates 
were picked and expressed (= 180 clones), as control pET28a-AtCCD1synv2 and pET28a 
empty vector were used. Controls are highlighted in black (positive) and red (negative), if not 
indicated otherwise, following wells were used for positive- (H1, E7, A12) and negative- (A1, 
E6, H12) controls. 
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4 Results 
4.1 AtCCD1 structure analysis and modeling 
AtCCD1 
Arabidopsis thaliana CCD1 consists of 538 amino acids with a calculated molecular weight of 
60.9 kDa, an isoelectric point of 6.05 and a charge at pH 7 of -8.55.58 No transit peptide or 
signaling sequence is reported, but the 5’-end contains ~40 amino acids which do not align 
with Aco1 and might be unordered or cleaved. Analysis using the signal-peptide prediction 
software SignalP, TargetP, ChloroP and TMHMM59 suggested no signal-sequence, 
cleavage-site or precursor for AtCCD1. The iron is coordinated by H222, H270, H336 and 
H523. AtCCD1 does not contain disulfide-bonds. 
4.1.1 Structure modeling of AtCCD1 
Only one crystal structure33 can be used to prepare homology models for CCDs. According to 
this structure, AtCCD1 was modeled using swiss-model60,61 (PDB code: 2biw chain A). The 
model lacks the first 38 amino acids, and the last 10 amino acids, starting with H39, the first 
amino acid assigned to an ordered secondary structure is P44 (α-helix) and the last T528 (β-
sheet). Based on the model, the surface-charges of AtCCD1 were calculated and are shown 
in Figure 5. The different surface-charges are visible; of special interest is the “white” area, 
which represents exposed hydrophobic residues, the so-called “hydrophobic patch”. This is 
usually not observed in proteins and indicates that AtCCD1 may be membrane-associated 
even though CCD1s being located in the cytosol19. 
  
Figure 5: (A) Bottom view along the propeller axis of AtCCD1, revealing the 7-bladed propeller structure. The four 
coordinating histidines are visible in the center. (B) Simulated surface charges of AtCCD1. Red represents a negative, blue a 
positive and white an uncharged surface. In the centre, the substrate channel with a hypothetical apo-8’-retinal is shown; 
the approximate propeller axis is indicated by a black line. 
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A clustalw62 comparison of AtCCD1 and 
Aco1 showed that most of the residues 
constituting the “hydrophobic patch” and 
responsible for the membrane attachment in 
Aco143 have a corresponding amino acid in 
AtCCD1 as summarized in Table 3. 
According to the generated homology model 
the “hydrophobic patch” of AtCCD1 can be 
assigned to three major loops: P86-G99, 
F130-V151 and I162-A172. The model 
further reveals a 4th loop, P290-M299, which 
comprises mostly positive charges. The loop 
also holds several exposed, hydrophobic 
residues: M293, V294 and M299. 
 
4.2 Constructed vectors 
AtCCD1synv2 
AtCCD1 contains several 
residues which are rare in E. coli. 
Plant and bacterial codon usage 
differ, so the gene was optimized 
for expression in E. coli and 
subsequently ordered as a 
synthetic gene. This eliminates 
the finding of expression mutants 
due to codon limitations in the 
wild type. For expression the 
vector pET28a(+) was selected 
and the synthetic gene inserted 
using restriction enzymes NcoI 
and HindIII at 5’- and 3’-termini, 
respectively. The construct was 
sequenced and a silent mutation 
Table 3: Comparison of the “hydrophobic patch” 
residues in Aco1
43
 and corresponding residues in 
AtCCD1. Conserved hydrophobic amino acids are 
highlighted in bold, polar ones in italics.  
 
Hydrophobic amino 
acid in Aco1 
Corresponding amino 
acid in AtCCD1 
W121 
L122 
I125 
F126 
L128 
L259 
L262 
F263 
L265 
L148 
L149 
I162 
I163 
N165 
K291 
V294 
K295 
K297 
 
Figure 6: Vector map of pET28a-AtCCD1synv2. Relevant restriction sites are 
shown, the black bar shows the position of the silent mutation. The map 
was created using Vector-NTI
58
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(D141) discovered. Activity was not impaired, so the resulting vector was transferred to the 
project partners and used for further experiments (Figure 6). 
pGex6p4 
For affinity tag purification of 
variants, a modified vector of the 
pGex-series was constructed. 
Complementary restriction sites 
to the pET28a(+) were inserted, 
allowing fast subcloning of any 
variant into the modified vector. 
The new construct is in frame 
with the commercial pGex6p1 
vector, so that it was named 
pGex6p4 (Figure 7). Compared 
to the original BamHI + XhoI 
restriction, the new sites showed much higher cloning efficiency; additionally no self-ligation 
of the vector was observed in control experiments. 
 
4.3 Expression of AtCCD1 
In vivo co-expression 
The construct pET28a-AtCCD1synv2 was co-expressed with β-carotene [pACCAR16ΔcrtX63] 
and zeaxanthin [pACCAR25ΔcrtX63] synthesis pathways to show its activity in vivo. The 
wildtype already showed complete bleaching for both of the produced carotenoids (Figure 8), 
so an in vivo screening system for improvements of AtCCD1 was not possible. 
 
 
Figure 7: Map of the created vector pGex6p4-AtCCD1syn. Positions of 
unique restriction sites are indicated. The map was created using Vector-
NTI
58
. 
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Expression in shaking flasks 
The construct pET28a-AtCCD1synv2 was 
expressed in E. coli and activity confirmed in 
vivo as well as in vitro. In the chosen 
expression system of pET vectors, the 
majority of AtCCD1 is expressed as 
inclusion bodies. Nevertheless, sufficient 
enzymatic activity was obtained in the cell 
lysate. Expression of the protein was also 
confirmed by SDS-PAGE (Figure 9). The 
expected mass of AtCCD1synv2 is 60.9 
kDa, the control AtCCD1His64 has ans 
expected mass of 66.0 kDa.  
 
      
Figure 8: E. coli BL21-Gold(DE3) expressing (A) pACCAR16ΔcrtX + pET28a(+) and pACCAR16ΔcrtX + pET28a-
AtCCD1synv2; (B) pACCAR25ΔcrtX +pET28a-AtCCD1synv2 and pACCAR25ΔcrtX +pET28a. 
 
Figure 9: 10 % SDS-polyacrylamide gel electrophoresis of 
AtCCD1syn (1), pET28a (2) and AtCCD1-His(3), “a” and “b” 
are soluble and insoluble fraction respectively. Expression 
is observed in 1 and 3 (arrow), while no expression is 
observed in the empty vector control (2). 
A B 
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Expression in MTPs 
For screening, reproducible and 
stable expression in the 96-well 
format is mandatory. Therefore, 
expression was evaluated by 
comparing the resulting 
enzymatic activity (nmol/ml/h). 
Several conditions were “tested” 
and finally active expression of 
AtCCD1 in MTPs was achieved. 
An intermediate result is 
illustrated in Figure 10, were the 
resulting activity was low and 
expression not homogeneous or 
reproducible. Expression had to be stopped after 15 h due to cell-lysis.  
 
Stable and reproducible activity 
could be obtained with co-
expression of lysozyme (pLysS), 
which also works as t7-promoter 
repressor65. E. coli showed stable 
expression for at least 36 h 
(Figure 11), best reproducibility 
and signal to noise ratio was 
obtained for LB induced with 
0.2 mM IPTG. Although 
expression of AtCCD1 was 
successful, the cells were 
severely influenced by the lysozyme, tampering transformation efficiency and complicating 
the handling of plates after expression. Both drawbacks were compensated by switching to 
pLysY – a NEB proprietary lysozyme variant that lacks the muramidase activity of lysozyme 
but retains the T7-promoter repression.  
AtCCD1 truncations 
Predictprotein66 was used to get an overview of the N-terminal structure of AtCCD1. 
According to the secondary structure elements, three truncations were chosen. They lack the 
first 16aa (Δ16), the first 39aa (Δ39) and the first 55aa (Δ55), respectively constructs were 
 
Figure 10: Activity towards apo-8’-retinal before utilisation of pLys, 
150µl expressed in MTP, 25°C, 700rpm, 30g/ml Kan, 0.2mM IPTG added 
for LB and TB, ZYM
50
 is an auto-induction media. Expression was 
stopped after 15h due to cell lysis. 
 
Figure 11: Activity towards apo-8’-retinal, 150µl expressed with + 
pLysS, 25°C, 700rpm, 30g/ml Kan, 0.2mM IPTG added for LB and TB, 8 
replicates per time point. 
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cloned into pGex6p1 and confirmed by sequencing. Silent mutations were observed in Δ16 
(E333) and Δ39 (D141). Figure 12 shows in vivo co-expression with pACCAR16ΔcrtX. 
Co-expression of pACCAR16ΔcrtX in E. coli showed that the N-terminal truncated CCDs are 
less active than the wild-type enzyme. Under non-inducing conditions, no bleaching 
occurred. Conversely, after induction slight decoloration was observed for variants Δ16 and 
Δ39 while Δ55 did not show any obvious bleaching. In fact the intensity of decoloration 
seems to correlate with the length of the N-terminal truncation, indicating that N-terminal 
deletions result in reduced enzymatic activity (Figure 12C). None of the truncations showed 
in vitro activity with apo-8’-retinal in Triton X-100 micelles. 
 
4.4 Apo-8’-retinal assay 
In the presence of molecular oxygen 
apo-8’-retinal is cleaved resulting in β-
ionone and the C17-dialdehyde, as 
illustrated in Figure 13. The apo-8’-retinal 
assay was utilized to measure 
performance increase of AtCCD1 in the 
presence of organic co-solvents.  
 
 
 
 
Figure 13: Cleavage reaction used to determine activity of 
AtCCD1 in vitro.  
A 
C Figure 12: (A) pGex6p1CCD1-WT, -Δ16; (B) -Δ55, -Δ39 
on agar plate (no IPTG) after overnight incubation at 
37°C. (C) Pellets of 2ml culture (LB + 0.5mM IPTG, 
expressed for 5h at 30°C) WT, - Δ16, - Δ39, - Δ55.  
 
B 
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Organic solvents 
AtCCD1 cleaves apo-carotenoids in vitro more efficient if low concentrations of organic 
solvents are supplemented45. It is not clear, if AtCCD1 is actually enhanced by addition of co-
solvents or primarily the micelles are affected. To address this question, the method of 
directed evolution was chosen and applied to AtCCD1. This is the first description of directed 
evolution on carotenoid cleavage di-oxygenases. Directed evolution has been used to evolve 
mono-oxygenases to improve stability with organic solvents67 prior to this research, but the 
di-oxygenases differ significantly from mono-oxygenases in substrates, reaction pathways 
and involved cofactors. 
 
Solvents of choice were ethanol (aliphatic, proticN, polar, logP: -0.31) and DMSO (aprotic, 
dipolar, logP: -1.3, logPow -2.03). They represent two structurally and functionally different 
organic solvents, which may have diverse effects on the micelles as well as the enzyme. 
Application of two different solvents enables more general statements of the solvent effect to 
the engineered enzyme. Both solvents are water miscible in any ratio, which allows a 
continued increase of selection pressure. The effect of ethanol on AtCCD1 has been 
described briefly45, whereas the influence of DMSO has not been investigated.  
4.4.1 Apo-8’-retinal for screening with ethanol 
For the screening process, two wavelengths were used: 
 
510 nm: OD510 is linearly correlated to the substrate concentration whereas the product (C17-
dialdehyde) has almost no absorption at this wavelength. 
 
408 nm: Synthesis of the C17-dialdehyde increases OD408. As the substrate and product 
spectra overlap, it is not useful for quantification but is used to validate OD510 values. 
Decrease of OD510 is accompanied with increased OD408, if the cleavage is successful. 
 
Determination of the enzymatic activity by substrate depletion (OD510) proved successful, 
whereas detection of the product is not feasible using absorption. Absorbance of β-ionone is 
also not suitable for measurements, as β-ionone is volatile and maximum absorbance is 
around 330 nm, overlapping the absorption spectra of the proteins. A detection using 
fluorescence of the C17-dialdehyde is possible but has not been investigated in detail. The 
strongest fluorescence was observed with excitation at 400 nm and emission at 600 nm. 
                                               
N
 protic, a molecular solvent which contains dissociable H
+
, aprotic solvents cannot donate hydrogen 
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Apo-8’-retinal absorption 
Absorbance and apo-8’-retinal concentration are linearly correlated between 0-200 µM. The 
absorption coefficient of a freshly prepared apo-8’-retinal solution in PBS is 0.048 OD/µM, 
which slightly decreases over time. Addition of organic solvents further influences and slightly 
reduces the absorption coefficient at 510 nm. Calculations and characterization are based on 
an absorption-coefficient of 0.046 OD/µM, to compensate for these effects. The lower 
detection limit was 1-5 µM solutions and the upper end is limited by the amount of substrate 
that can be brought into micelles and exceeds 250 µM. This range might be extended to both 
ends with a tuned detection setup; however this has not been investigated. 
Limitation of the assay 
Micellar solutions of apo-8’-retinal 
are affected by organic solvents, 
as described in section 2.3 and 
5.4 With increased addition of 
organic solvents, the solution 
gets unstable which can be 
observed if the OD of the micellar 
solution is followed for a time 
period (Figure 14). The figure 
also shows that the micellar 
solution is stable up to 25 % (v/v) 
or 4.28 M ethanol and then 
drops, i.e. the apo-8’-retinal starts 
precipitating if the solution 
exceeds 4.28 M ethanol.  
 
For screening, the stability of the system had to be assured for the time of measurement, e.g. 
at least one hour. Therefore the described screening system was used up to 3.75 M ethanol. 
Assay deviation in a MTP 
The apo-8-retinal screening system was validated using a MTP. With application of the 
optimized expression system (chapter 3.2.3) and the developed assay (chapter 0, 10 % 
ethanol), an average activity of 28.7 nmol/ml/h (true) was obtained, corresponding to a 
conversion of 2.87 nmol apo-8’-retinal/well/h. The standard deviation was 10.5 % and 10.2 % 
for true and apparent values, respectively. The low blank value shows that the micelles are 
stable and no side reaction occurs in the E. coli lysate, further the micelles are stabilized in 
 
Figure 14: Stability of apo-8’-retinal micelles in PBS (no enzyme added) 
plotted against ethanol concentration (blue). Error-bars are calculated by 
four replicates, a trendline is added in brown. “Zero” represents a stable 
solution; values below zero show an impaired stability. 
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the E. coli lysate resulting in lower blank values compared to pure buffer solutions (Figure 
15).  
 
4.4.2 Pre-incubation with ethanol 
As stated above, the standard 
assay was limited to 3.75 M 
(22 % v/v) ethanol or 4.51 M 
(32 % v/v) DMSO (chapter 4.4.3). 
To improve AtCCD1 performance 
with higher organic solvent 
concentrations, the assay needed 
to be adapted. For this a “pre-
incubation” method was 
developed and evaluated, it is 
described in chapter 3.4.1. CCD1 
which contains cell lysate was 
incubated with the desired ratio of ethanol, afterwards the solution was diluted to a feasible 
ethanol concentration (e.g. 3.75 M) and activity measured using the micellar system 
described before. A proof of concept is shown in Figure 16, as expected the pre-incubation 
reduces AtCCD1 activity. No activity is observed if AtCCD1 is incubated at 6 M ethanol or 
higher concentrations. Peak activity was observed at 1.71 M ethanol, and was reduced by 
 
Figure 15: Activity of AtCCD1 in MTP with 10% (v/v) ethanol, expressed with pLysS. Apparent values in brown, and values 
after subtraction of the pET28a empty vector control in blue (true).  
 
Figure 16: Apo-8’-retinal directly screened at the given ethanol 
concentration (blue) and pre-incubated at twice the concentration 
(brown) as shown on the x-axis. No activity is observed if pre-
incubation occurs above 30 % ethanol (empty squares), errorbars were 
not determined. 
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pre-incubation with higher concentrations of ethanol. Effects of organic solvents on the 
micellar solution are further discussed in section 2.3 and 5.4. 
4.4.3 Apo-8’-retinal for screening with DMSO 
The screening system with DMSO was established utilizing the same principles as for the 
ethanol screening protocol. 
Determination of micelle stability with DMSO 
Stability of apo-8’-retinal 
micelles in PBS with 
supplementary DMSO was 
determined. For concentrations 
of up to 4.5 M (32 % v/v) of 
DMSO, the micelles are stable 
and the results reproducible. 
Exceeding this concentration, 
homogeneity is reduced first, 
followed by a disintegration of 
the micelles which can be seen 
by the decrease in absorbance 
(Figure 17). 
 
Normalized activity for different DMSO concentrations 
The gradient curve for AtCCD1 
with DMSO was determined and 
normalized to maximum activity. 
In directed evolution a residual 
activity of 20 % has been proven 
as a promising start for activity 
improvement.  Figure 18 shows 
that 20 % remaining activity are 
observed at >37 % DMSO, 
however stability properties of 
the micelles limited screening to 
4.51 M (32 % v/v) DMSO, which 
can be obtained from Figure 17. 
The concentration of DMSO for screening was set to 4.51 M and the reproducibility of the 
 
Figure 17: Stability of apo-8-micelles in DMSO and PBS, 8 replicates for 
each measurement. Blue represents a gradient from 0-27.5%, red a 
different experiment covering 15-45% DMSO in the assay. 
 
Figure 18: Activity profile for CCD1 over a range of DMSO concentrations. 
Eight replicates per point, errorbars calculated out of replicates, blue and 
brown show two separate experiments. Above 37% DMSO, no active 
enzymatic activity was observed (empty squares) 
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screening assay determined. True standard deviation was found to be 9.8 % (9.5 % 
apparent)68, exceeding reproducibility compared to the ethanol assay.  
 
4.5 Carotenoid assay 
The conversion of different 
carotenoids with AtCCD1 is 
interesting and has been 
reported before71. If uncleaved 
carotenoids are used as 
substrate, two symmetric 
cleavage reactions occur. A 
reaction scheme for zeaxanthin 
is shown in Figure 19.  
β-carotene, zeaxanthin and 
astaxanthin were investigated, 
out of these, β-carotene is the 
most interesting substrate 
choice. In contrast to  
β-carotene, the oxygen in zeaxanthin and astaxanthin renders them less hydrophobic and 
AtCCD1 converts both of them readily in vitro, so they may be used as substrates in high-
throughput screening systems. Two independent screening systems for conversion of 
zeaxanthin were developed, one based on fluorescence of the central cleavage product 
(C14), the other on substrate depletion by following absorbance of zeaxanthin. 
 
Figure 19: Reaction scheme for AtCCD1 utilizing zeaxanthin.  Cleavage 
positions and products are shown, in the case of alternative substrate 
astaxanthin an additional carbonyl-group (x) is present before and after 
cleavage, β-carotene contains neither carbonyl- nor hydroxyl-group. 
Absorption data are obtained from literature for dialdehyde
69
, 3-hydroxy-β-
ionone
69,70
, 3-hydroxy-β-ionone
70
 and zeaxanthin
49
. 
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4.5.1 Fluorescence assay 
Fluorescence can be observed 
when zeaxanthin is cleaved by 
AtCCD1 and the solution is 
exited at 366 nm. To develop 
optimal conditions for a 
screening assay, these effects 
were quantified and are 
summarized in Figure 20. Two 
fluorescence peaks are 
observed at 365 nm / 510 nm 
and 345 nm/ 510 nm (excitation/ 
emission). Standard deviation 
has been determined using a 
reference plate and was found 
to be less than 26 % after 19 h, 
with a signal to noise ratio >10 
(CCD1 vs. control). This assay 
can be directly transferred to 
other carotenoids, independent 
of their terminal modifications. 
Possible carotenoids are e.g. 
astaxanthin, β-carotene, lutein, 
antheraxanthin, β-kryptoxanthin, 
violaxanthin. 
 
  
 
Figure 20: The absorption spectra of CCD1 converting zeaxanthin (A), 
whereas the red curve is a negative control (pET28a) and blue the 
samples (CCD1). The corresponding 3D fluorescence for the CCD1 
sample is shown (B) and the control in (C). For the fluorescence, 
excitation wavelength is given on the right (nm) and emission 
wavelength (nm) below. 
 
 
 
A 
C  
B 
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4.5.2 Zeaxanthin depletion 
Conversion of zeaxanthin can be monitored by following the decrease of substrate, e.g. at 
463 nm. In contrast, analysis of product formation by absorption was not suitable as the 
protein and used surfactants also absorb at the corresponding wavelength (Figure 20 A). The 
absorption coefficient of zeaxanthin in Tween 40 micelles has been determined for 463 nm 
and 491 nm with 0.0799 and 0.0606 OD/µM, respectively and a reliability of r²>0.998 for 
concentrations of 0-85 µM. The advantage of the substrate depletion is the quick assay 
performance of less than 1 h whereas complete fluorescence development can take up to 
19 h (Figure 21). 
 
4.5.3 TLC separation of carotenoids 
The samples of AtCCD1 with zeaxanthin and vector control were spotted on thin layer 
chromatography plates to separate substrate and product. Reverse-phase-C18 silica plates 
showed a good separation, whereas standard silica plates did not apart product and 
substrate efficiently (data not shown). Product and substrate were analyzed spectrometrically 
 
 
Figure 21: Fluorescence development of zeaxanthin incubated with AtCCD1 in 96well. The 
solution is cleared completely after 4-5 h, but no fluorescence is observed (4 h red, 5 h blue), 
after further incubation a strong fluorescence develops (19 h green). X-axis shows the wells, 
whereas 1-4 are empty vector controls (pET28a), 6-96 are AtCCD1 samples. Y-axis shows the 
increase in fluorescence in multiples of the initial value. 
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and the remaining substrate showed the estimated triplet absorption peak, whereas the 
cleavage product peak shows a hypsochromic shift (Figure 22). 
 
4.6 Generation of diversity 
Four different methods and five iterative rounds of directed evolution were performed and 
analyzed. This enabled utilization of different techniques and the bias of each method could 
be complemented in a subsequent round of mutagenesis. In this chapter, mutagenesis 
techniques and libraries are described; the resulting mutations are shown in chapter 4.7 
4.6.1 ep-PCR mutagenesis 
AtCCD1 was analyzed with MAP54 and a method with biased distribution of nucleotides 
(G>>ACT) chosen for ep-PCR-library 1. This method is characteristic for a biased exchange 
of amino acids, low number of stop-codons, good average acid substitution. Cloning was 
done using megawhoop55, and a library consisting of 12 plates (1080 clones) picked. The 
library was first screened for apo-8’-retinal activity at 3.6 M ethanol and later on at 4.5 M 
 
Figure 22: (A) Zeaxanthin reverse phase TLC. Lanes 1-3 are vector controls, lanes 4-6 are converted with CCD1. The 
substrate remains close to the spotting area (RF~ 0.0), the cleavage product is partitioned into three independent peaks 
(RF~ 0.58, 0.63, 0.72) Absorption spectra of the indicated peaks are shown in the top-right (B). 
 
B A 
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DMSO and 2.35 M 2-propanol. The second round, ep-PCR-library 2 was based on improved 
variants from ep-PCR-library1 and created using the same method, mutagenesis and cloning 
conditions. A library of 1980 clones was picked and screened at 3.77 M ethanol for apo-8’-
retinal utilization. The improved variants here were then used for ep-PCR-library 3, where a 
different mutagenesis method54,72 was used. This method should also produce transversions 
(T->A and A->T) and reduce the amount of A->G and T->C mutations. 900 clones were 
picked and screened for remaining apo-8’-retinal conversion after pre-incubation with 5.5 M 
ethanol. The same library was later on screened for zeaxanthin conversion without 
supplementing organic solvents. The results of the two different screening methods diverged 
and the best mutants of each screening method were used for a subsequent round,  in which 
the SeSaM random mutagenesis method was applied. 
 
4.6.2 SeSaM mutagenesis 
Three rounds of SeSaM73,74 were generated to enhance diversity and produce mutations that 
are rare or not obtainable with conventional ep-PCR, e.g. a strong transversion bias and 
consecutive mutations. The first library (SeSaM-library1) was based on ep-PCR-library3 
screened for ethanol stability. The SeSaM recombinatorial protocol was applied, which 
enables recombination of existing mutants but has an increased mutational load. The library 
was cloned using the megawhoop55 protocol. A low ratio of activity was obtained (3.3 55 
protocol. A low ratio of activity was obtained (3.3%) and only a small library created (360 
clones) and screened for apo-8’-retinal conversion after pre-incubation with 5.5 M ethanol. 
However, two interesting and improved variants were found and used as template for 
SeSaM-library 2, where the classical approach was applied and “classical cloning” performed 
using NcoI and HindIII. 540 clones were picked and screened for apo-8’-retinal conversion 
after pre-incubation with 5.5 M ethanol. The activity ratio at this screen was 6.8 % but still a 
high ratio of secondary mutations was observed. 
 
Detached from the apo-8’-retinal development, a development towards improved zeaxanthin 
conversion was followed. The best variants from ep-PCR-library 3 (zeaxanthin conversion) 
were also taken for a SeSaM-library 3, created with the classical protocol, in parallel to 
SeSaM-library 2. Identical to SeSaM-library 2 (classic protocol), restriction and ligation was 
used for cloning and 540 clones picked and screened, using the fluorescence as well as the 
substrate depletion assay. The results obtained were identical but not better than achieved in 
the parent round.  
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4.7 Screening results 
4.7.1 Improved ethanol stability 
Ethanol was used as organic solvent for AtCCD1. To improve the stability and activity of 
AtCCD1 with ethanol, five rounds of mutagenesis and screening were performed. The 
activity as well as stability of AtCCD1 against ethyl alcohol was significantly improved. Figure 
23 shows the results of a mutant after 3 rounds of evolution, where 20 % remaining activity 
after exposure with ethyl alcohol is improved from 4.5 M (wildtype AtCCD1) to 6 M (M1-
S264G-S363G); additionally, peak activity is increase more than 1.6 fold. 
 
 
 
Below the findings of each library screened are summarized. New mutations are highlighted 
in bold; mutations that might be inherited are not highlighted. For technical reasons, it cannot 
be determined in all cases if a mutation is inherited or if the same mutation was acquired 
again. 
  
                                               
O
 BSA = bovine serum albumine 
 
Figure 23: Conversion of apo-8’-retinal by purified AtCCD1 mutants at different concentrations of ethanol. Samples were 
diluted to the equal amounts of active CCD1 as well as equal amounts of total protein (by addition of BSA
O
), to avoid 
effects that may be caused by protein precipitation. 
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ep-library 1 
Table 4: Summary of ep-PCR-library 1 screened for apo-8’-retinal conversion with ethanol. Clones are analyzed on the 
amino acid level as well as on the DNA level. New mutations are indicated in bold. 
Amino acid changes I10V S363G  none 
Nucleotides -6NT: T->C (Ts) 
+28NT: A->G (Ts) 
+1087NT: A->G(Ts) -4NT: T->C (Ts) 
Code L1P2E2 (4) L1P3C9 (2) L1P4F6 (1) 
ep-library 2 
Table 5: Summary of ep-PCR-library 2 screened for apo-8’-retinal conversion with ethanol. Clones are analyzed on the 
amino acid level as well as on the DNA level. New mutations are indicated in bold, not highlighted mutations may be 
inherited from earlier rounds. 
Amino acid changes S363G I10V-S24G-S363G S363G-Q539 
Nucleotides +1087NT: A->G(Ts) -6NT: T->C (Ts) 
-5NT: A->G (Ts) 
+28NT: A->G (Ts) 
+70NT: A->G (Ts) 
+1002NT: T->C (Ts) 
+1087NT: A->G (Ts) 
+1329NT: A->G (Ts) 
 
+1087NT: A->G(Ts) 
+1206NT: T->C(Ts) 
+1615NT: T->C(Ts) 
Code L2P8C4 (A8) L2P11C5 (A10) L2P22A12 (E11) 
ep-library 3 
Table 6: Summary of ep-PCR-library 3 screened for apo-8’-retinal conversion with ethanol. Clones are analyzed on the 
amino acid level as well as on the DNA level. New mutations are indicated in bold, not highlighted mutations may be 
inherited from earlier rounds. 
Amino acid changes M1-S264G-S363G S363-Q539 I10V-S363G 
Nucleotides +1NT: A->G (Ts) 
+790NT: A->G (Ts) 
+1087NT: A->G(Ts) 
+1087NT: A->G (Ts) 
+1206NT: T->C(Ts) 
+1615NT: T->C(Ts) 
-6NT: T->C (Ts) 
+28NT: A->G (Ts) 
+1087NT: A->G (Ts) 
Code L3P2B2 L3P4G6 L3P6D5 
    
Amino acid changes I10V-S363G I10V-S363G S363-Q539 
Nucleotides -6NT: T->C (Ts) 
+28NT: A->G (Ts) 
+249NT: C->T(Ts) 
+1087NT: A->G (Ts) 
-6NT: T->C (Ts) 
+28NT: A->G (Ts) 
+249NT: C->T(Ts) 
+1087NT: A->G (Ts) 
+1087NT: A->G (Ts) 
+1206NT: T->C(Ts) 
+1615NT: T->C(Ts) 
Code L3P7A6 L3P2F5 L3P2H2 
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SeSaM library 4 
Table 7: Summary of SeSaM-library 4 screened for apo-8’-retinal conversion with ethanol. Clones are analyzed on the 
amino acid level as well as on the DNA level. New mutations are indicated in bold, not highlighted mutations may be 
inherited from earlier rounds. The shown mutants performed better as the selected reference mutant S363G. 
Amino acid changes I10V-S264G-S363G S363G-T536G-Q539 I10V-S264G-S363G 
Nucleotides -6NT: T->C (Ts) 
+28NT: A->G (Ts) 
+790NT:A->G (Ts) 
+1087NT: A->G (Ts) 
+1087NT: A->G (Ts) 
+1606NT: A->G (Ts) 
+1607NT: C->G (Tv) 
+1615NT: T->C(Ts) 
-6NT: T->C (Ts) 
+28NT: A->G (Ts) 
+790NT:A->G (Ts) 
+1087NT: A->G (Ts) 
Code S1P1A4 S1P3B7 S1P2E12B 
 
Mutant S1P3B7 shows the characteristics of a SeSaM mutation, which is a transversion 
followed by transition. The two other mutants show the same recombination pattern of 
already known mutations. 
 
SeSaM library 5 
Table 8: Summary of SeSaM-library 5 screened for apo-8’-retinal conversion with ethanol. Clones are analyzed on the 
amino acid level as well as on the DNA level. New mutations are indicated in bold, not highlighted mutations may be 
inherited from earlier rounds. 
Amino acid changes S9N-E507K I10V I10V-A41T 
Nucleotides +26NT: G->A (Ts) 
+249NT: C->T (Ts) 
+1519NT:  G->A (Ts) 
+28NT: A->G (Ts) 
+1266NT: T->C (Ts) 
+1503NT: G->T (Tv) 
+28NT: A->G (Ts) 
+121NT: G->A (Ts) 
+249NT: C->T (Ts) 
+1575NT: G-A (Ts) 
Code S2P3H9 S2P3F7 S2P6F1 
    
Amino acid changes I10V 
Nucleotides +28NT: A->G (Ts) 
+249NT: C->T (Ts) 
Code S2P5D3 
 
This library was cloned using restriction sites NcoI and HindIII at the startcodon, so all 
mutations in front of the start codon (+1NT) are removed. 
4.7.2 Improved conversion of zeaxanthin 
To improve utilization of whole carotenoids without organic co-solvents, the already improved 
variants in the ep-PCR-library 3 were screened again for conversion of zeaxanthin. Following 
improved variants were found: 
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ep-library 3 
Table 9: Summary of ep-PCR-library 3 screened for zeaxanthin. Found mutations are given on the amino acid level as well 
as on the DNA level. New mutations are indicated in bold, not highlighted mutations may be inherited from earlier 
rounds. 
Amino acid changes I10V I10V-V194A I10V-S397G 
Nucleotides -6NT: T->C (Ts) 
+28NT: A->G (Ts) 
+249NT: C->T(Ts) 
 
-6NT: T->C (Ts) 
-5NT: A->G (Ts) 
+28NT: A->G (Ts) 
+581NT: T->C (Ts) 
-6NT: T->C (Ts) 
+28NT: A->G (Ts) 
+249NT: C->T(Ts) 
+1189NT: A->G(Ts) 
Code L3P4C9 L3P6G9 L3P9H10 
   
Amino acid changes  none  
Nucleotides -4NT: T->C (Ts) 
Code L3P8F1 
SeSaM library 6 
Table 10: Summary of SeSaM-library 6 screened for zeaxanthin. Found mutations are given on the amino acid level as 
well as on the DNA level. New mutations are indicated in bold, not highlighted mutations may be inherited from earlier 
rounds. 
Amino acid changes I10V I10V-S264G-S363G-
L421V 
I10V 
Nucleotides +28NT: A->G (Ts) 
 
+28NT: A->G (Ts) 
+309NT: T->C (Ts) 
+790NT: A->G (Ts) 
+1087NT: A->G (Ts) 
+1261NT: C->G (Tv) 
+28NT: A->G (Ts) 
 
Code S3P4D3 S3P1B4 S3P4A10 
  
Amino acid changes I10V-A475E 
Nucleotides +28NT: A->G (Ts) 
+1424NT: C->A (Tv) 
Code S3P5F4 
 
4.7.3 Site saturation mutagenesis 
Site saturation was used to further improve and investigate the amino acid positions that 
were found using directed evolution. The QuickChange site-directed mutagenesis protocol 
which was developed by Stratagene [La Jolla, CA, USA], is one of the most widely used 
PCR-based mutagenesis methods. The method uses two complementary synthetic 
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oligonucleotides that contain the desired mutation as primers and plasmid DNA as a 
template to synthesize the double-stranded, circular mutant PCR product. To increase 
performance, a 2-step procedure is used57, which reduces the hybridization that occurs 
between the forward and reverse primer. 
SS363 
The diverse results of S363 when 
screened for ethanol stability or 
zeaxanthin conversion led to this 
site being investigated in detail 
by site-saturation. 363G, the 
already determined glycine 
substitution, performs best when 
screened for ethanol resistance 
with almost 1.5 fold increase 
compared to the wild type at 
3.75 M ethanol. On the other 
hand, zeaxanthin was utilized 
best by 363T, which had a 1.6 
fold improved performance 
compared to the wild type. Additionally both mutations perform worse than the wild type 
when checked for the not evolved conditions. Figure 24 shows a direct comparison of the 
mutants. 
 
4.8 Purification, storage and structure of AtCCD1 
4.8.1 Tag-free purification 
Conclusions about stability improvements 
of AtCCD1 variants may be diminished, if 
fusion proteins (e.g. GST) are used. At the 
same time purification followed by 
cleavage of the used tag can lead to 
impurities and in the case of CCD1 to 
inactivation of the protein. These 
deficiencies were avoided by developing a 
tag-free purification protocol. Standard 
purification methods e.g. anion-exchange, cation-exchange, hydrophobic-interaction-
 
Figure 24: Performance of 363G and 363T relative to wild type. Screening 
conditions are indicated, error-bars calculated out of replicates (6 for 
WT, 4x 363G and 2x 363T). 
 
Figure 25: from left to right: ladder, pET28a, L3P9H10, WT, 
S3P5F4, I10V, S363T, S2P3H9, S2P6F1, ladder  
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chromatography (HIC) were examined, but did not yield satisfactory activity and purity (data 
not shown). In the end a purification based on the solubility properties of AtCCD1 proved to 
be successful. After cell lysis, all soluble proteins were removed and the pellet washed with 
PBS. Then PBS +0.2 % Triton X-100 was added which released AtCCD1 from the pellet. 
Following centrifugation, the enriched fraction of active CCD1 was obtained in the 
supernatant and could be further polished. A size-exclusion chromatographic step was 
added, to ensure monodispersity of the protein sample. The full protocol is described in 
section 3.2.2. Figure 25 shows a 10%-SDS-PAGEP of purified AtCCD1 mutants, yield and 
purity were determined as described in chapter 3.2.2. 
 
4.8.2 Stability in 15 % ethanol 
The influence of long-term exposure to organic solvent 
was investigated with tag-free purified AtCCD1. A fresh 
purified sample was stored at 4°C with ethanol (15 % 
v/v) and a control without ethanol (15 %, v/v PBS 
added). The concentration was chosen to be similar to 
the observed peak maximum at 15 % ethanol, and the 
sample sealed and stored for one week. Ethanol was 
added to the control and PBS to the incubated sample 
to balance the ethanol concentration during 
determination of enzymatic activity. AtCCD1 stored in 
the presence of ethanol was found to have 65 % 
remaining activity compared to the control, which is 
shown in Figure 26 . 
                                               
P
 SDS-PAGE = sodium-dodecyl-sulfate polyacryl-amide-gel-electrophoresis 
 
Figure 26: Conversion of apo-8’-retinal by 
AtCCD1 after one week of storage at 4°C, 
error bars calculated by three replicates. 
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4.8.3 CD-spectra 
To monitor and observe the effect that the organic solvents have 
on AtCCD1, the protein was purified and analyzed using circular-
dichroism (CD) in the far UV-spectra (190 nm – 250 nm). A GST-
fusion construct was used for purification, which was done in four 
steps; GST-affinity, cleavage, counter-affinity and a final gel-
filtration step. No DTT was added, because of its absorption75, the 
purified fraction is shown in Figure 27, an SDS-PAGE image. CD-
spectra were recorded for the native protein, and supplemented 
with organic solvents, e.g. 5-25 % ethanol, 5-15 % 2-propanol and 
10 % tetra-fluoro-ethanol. The CD-values, an intensity difference 
between left and right circular polarized light beams, is expressed 
in “milli-degree” (mdeg). Milli-degrees were converted into “mean 
residues ellipticities” (Ɵ), which allows deconvolution for 
predictions of the secondary structure composition. Structure 
predictions are summarized in Table 11. Alpha helices were calculated using the algorithm 
“α-helices by elliptics”52, β-sheets and random using the K2D neural network53. If both 
algorithms yielded dissimilar results (*), the value predicted by the further algorithm is given. 
It should be noted that the sum of all structure elements is not necessarily 100 %. 
 
Table 11: Structure prediction of AtCCD1 with and without organic co-solvents. Inconsistent prediction of the α–helix 
content by the two used algorithm is indicated with * 
Native 0% TFE
Q
 10%   
α-helices: 15% α-helices: *14%   
β-sheets: 32% β-sheets: 28%   
random coil: 53% random coil: 54%   
 
      
Ethanol  5% 15% 20% 22.5% 25% 
α-helices: *10% 15% 14% 16% *9% 
β-sheets: 35% 30% 27% 30% 45% 
random coil: 54% 53% 54% 52% 47% 
 
      
Isopropanol 5% 10% 15%   
α-helices: 10% *10% 14%   
β-sheets: 36% 33% 30%   
random coil: 55% 52% 54%   
 
                                               
Q
 TFE = tetra-fluoro-ethanol 
 
Figure 27: AtCCD1 after final 
gel filtration step. Lane 2 was 
used for CD, lane 1 and 3 
discarded. Arrows indicate 
the double band observed 
after purification, M is a 
protein standard. 
- 41 - 
Prior to deconvolution the blank-values were subtracted for each sample. The resulting 
curves are displayed in Figure 28. 
Interpretation of the spectra is complex, but some indications can be drawn. The 
determination of α-helices by52 uses exclusively the absorbance at 222 nm. A lower mdeg-
value results in a higher fraction of α-helices. Also α–helices usually show a “dip” around 
210nm, which can be clearly seen for the native protein sample. The determination of  
β–sheets and random coils is not directly possible, but the more the curves deviate from the 
native curve, the stronger is the effect on the secondary structure – which indicates 
denaturation. In Figure 28 strong effects can be seen for 10 % TFE (B) and 25 % ethanol 
(C). 
4.9 Assays not applicable with AtCCD1 
Oxygen consumption in oxoplates 
Oxoplates show an increase in fluorescence if the oxygen in the buffer solution is reduced, 
enabling an indirect assay based on the formation of aldehydes that utilize the dissolved 
oxygen in the buffer. Oxoplates are advantageous in the following properties: No detection of 
the product is needed, fluorescence is measured independent of OD limitations and 
fluorescent assays usually have a high sensitivity. Limitations that arose during applications 
included: Diffusion of air dissolved oxygen to the 384well plate in the observed assay time of 
3h. This was solved by covering the used wells with light mineral oil. The applied substrate 
concentration (e.g. 67.2 µM of apo-8’-retinal) determines the maximum amount of oxygen 
 
Figure 28: CD-curves for AtCCD1 without organic co-solvents (A), in the presence of Tetra-fluroethanol (B), in the 
presence of ethanol (C) and 2-propanol (D). Calculation of secondary structures (Table 11) is based on the deconvolution 
of the shown graphs. 
A 
C 
C 
D 
B 
D 
B A 
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that can be converted. Aqueous buffers have ~278 µM dissolved oxygen due to  the oxygen 
exchange with air. Therefore at least the same amount of substrate is needed to obtain 
complete conversion – quantities that have not been achieved with AtCCD1. Finally the 
sensitivity of the assay increases exponentially with the decrease of oxygen (fluorescence 
quenching according to Stern-Volmer-equation). Therefore oxoplates are very sensitive for 0-
5 % oxygen and less sensitive for 10-21 % oxygen. In summary the sensitivity is too low for 
current screenings with AtCCD1. 
NBT – Nitro-Blue-Tetrazolium assay 
In the original paper, NBT is a multiple staged reporter assay, where the formation of 
aldehydes is shown by the development of blue formazan76. To apply the assay, an 
appropriate ALDHR is needed, which transfers the hydrogen of the built aldehydes to NAD+ 
or NADP+. In a second step NAD+ is reduced by PMSS & NBT to form formazan, which can 
be easily detected. For AtCCD1, an ALDH that works on long conjugated double-bound 
aldehydes would be required. In collaboration with Professor Jäger (FZ Jülich) no 
appropriate ADLH could be identified by screening 200 candidate genes. Additionally, the 
resulting aldehyde needs to be available for the ALDH, which is likely but not guaranteed 
with the micellar approach. 
 
Agar plate assay 
Solid phase screening systems have been proven to enable prescreening of active and 
inactive clones. The substrate solution was added to agar when pouring plates (20 µM IPTG, 
50 mg/l kanamycin and 28 mg/l apo-8’-retinal or 15 mg/l β-carotene), leading to 
corresponding colored agar plates. If functional expressed AtCCD1 could utilize the 
substrate, colorless colonies or bleaching of the agar might be observed. White colonies 
were observed when CCD1 was expressed in E. coli on the agar plates, whereas vector-
controls remained translucent. Nevertheless, the same happens on control-plates without 
substrate, demonstrating that the white color is not caused by substrate conversion. It may 
be that the white culture was caused by CCD1 aggregates (inclusion bodies). Further testes 
with E. coli lysate containing active AtCCD1 on agar-plates showed no decoloration, 
indicating that the carotenoid in the agar is not converted by  AtCCD1. 
                                               
R
 ALDH = aldehyde dehydrogenase 
S
 PMS = phenanzine methosulfate 
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Apo-8-retinal for screening with isopropanol 
A screening system for AtCCD1 activity with 2-propanol was developed77. The system 
proved to be less reproducible than the protocols for ethanol or DMSO. Precipitation was 
observed earlier than for DSMO or ethanol, additionally the micelles were not stable above 
2 M 2-propanol (v/v in PBS without E. coli lysate). For screening conditions, 2.35 M 
2-propanol (v/v in PBS and E. coli lysate) were chosen and a standard deviation of 20.8 % 
(apparent) and 22.6 % (true) achieved (data not shown). The system was not pursued 
further. 
Aldehyde detection with schiffs-reagent 
Chemically, aldehydes can be detected using schiff’s-reagent forming a purple complex. This 
general aldehyde detection assay should also work for the aldehydes formed by AtCCD1, 
which are C14 or C17 depending on the substrate. The detection limit was determined by 
dilution series using acetaldehyde. It was found to be in the mM range, with 17.8 mM 
acetaldehyde showing instant coloration and 1.78 mM showing color development after five 
minutes. In the described screening assays (chapter 4.4) usually 67 µM of substrate was 
used, remaining at least one order of magnitude below the detection limit of schiffs-reagent. 
Additionally, cross reactions with the used detergents were not investigated but are likely and 
it is not known how the sensitivity of the schiff’s-reagent assay is influenced by the 
conjugated structure of the formed aldehydes. 
Determination of the melting curve using Cypro-orange 
Cross reactions of purified AtCCD1 (that contains Triton X-100) with cypro-orange lead to 
inconsistent data, a maximum slope and correlated melting point could not be determined 
(data not shown). It is expected that the hydrophobic interactions of AtCCD1 and Triton  
X-100 with cypro-orange lead to background fluorescence. 
Determination of the protein concentration using OD280nm 
Methods that use OD280 for quantification may not be used with AtCCD1 as soon as Triton  
X-100 is involved, due to an absorbance overlap. This might be avoided by using 
hydrogenated Triton X-10078, but has not been investigated further. To our knowledge, CCD1 
can only be quantified reliable using electrophoresis methods such as SDS-Page or the 
Bioanalyzer 2100 [Agilent Technologies, USA]. Standard protein determination kits e.g. BCA-
kit [Thermo-Scientific] are affected but may still work. 
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5 Discussion 
5.1 Expression of AtCCD1 
Expression conditions were kept close to the published protocols and unpublished results 
from the research group of PD Dr. Jens Schrader at the Karl Winnacker Institut in Frankfurt. 
All created vectors showed equal or slightly improved expression compared to the original 
gene, expression in shake flasks was only significant when temperatures of 20 °C or less 
were used. Lowering the temperature further to 18 °C proved successful and increases the 
expression of active CCD1.  
pLysY 
In microtiter-plates AtCCD1 could be expressed at 25°C by utilization of a 2nd plasmid pLysY 
and supplementary chloramphenicol. In contrast to the often used pLysS65, pLysY expresses 
the T7 inhibitor lysozyme which does not exhibit the muramidase activity of original lysozyme 
(K128Y-mutation) [NEB], which improved handling of the E. coli cultures and led to higher 
transformation efficiency. The pLysY-plasmid uses the chromosomal origin mini-F, which 
allows cultivation and usage without addition of selective antibiotics, however when 
expressing AtCCD1 with pLysY and no chloramphenicol, observed activity was less than with 
supplementary chloramphenicol (data not shown). Enzymatic activity was not further 
enhanced if pLysY and chloramphenicol were used in 1 l shaking flasks at 18 °C. Indications 
into the same direction were obtained by changes found at the ribosome binding site during 
the mutagenesis rounds. Several mutants were found with mutations just in front of the start 
codon. Transitions of A/T bases to G/C were found at positions -4, -5 and -6bp, which lower 
the transcription rate of the affected genes. Further, usage of glucose containing media in the 
pre-culture enhances expression levels, best results were obtained using MDG media50.  
 
Co-expression of pLysY has an impact on the enzyme fold and activity and was essential for 
reproducible and active expression of AtCCD1in MTPs. However, it might be a more non-
specific deceleration of the expression rather than an active involvement in the folding 
process. For future expression it might be advisable to investigate weaker promoter systems, 
or constructs that can be fine-tuned for expression such as the arabinose expression 
system50.  
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5.2 Structure, circular dichroism and modeling 
Structure 
AtCCD1 is the best investigated 
plant CCD; yet the knowledge 
about structure, function and 
folding is limited.  
 
Figure 29 shows the residues 
found to have an impact on any 
of the investigated properties. 
All amino-acids were surface 
exposed residues in loops or 
unstructured regions; none was 
in proximity to the reaction 
center. Green residues are 
located in the putative 
membrane- or surfactant-
interface and may be involved in 
membrane or micelle 
integration. Red residues are 
located on the opposite of the protein, below the central beta-sheet-propeller. An access 
tunnel, from the bottom to the reaction site is reported for Aco1 - its function remains 
obscure, but might involve oxygen delivery7,33. The amino acid substitution closest to any of 
the four active-side determining histidines is S264G (not visible in Figure 29), six positions 
away from H270. Amino-acid 264 is a surface exposed residue close to the substrate 
entrance channel. S264 is not in close proximity to any other determined residue, neither is 
A41 or V194 or L421.  
 
N-terminal truncations were generated and remaining, yet reduced carotenoid bleaching of 
AtCCD1 mutants without the first 16 as well as the first 39 amino acids shown (chapter 4.3). 
The observed activities agree with the predictions (chapter 4.1) and structure analysis of 
Aco133 that the n-terminus is not essential for folding of the protein, but most likely essential 
for the enzyme-substrate interaction. In the N-terminal region following mutations were found 
by the directed evolution experiments: S9N, I10V, S24G and A41T.  
 
 
Figure 29: Ribbon view of AtCCD1 and highlighted determined residues. 
The residues are grouped by their position, putative surfactant-enzyme 
interface (green), below the propeller (red), other surface residues 
(orange). S264 and S397 are not visible in this projection. 
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Out of these four, the best investigated is I10V that proofed superior performance and yields 
during screening under all investigated conditions. Characterizations of the specific activity 
have not shown significant improvements, indicating that the stability and expression in  
E. coli is improved, but the residue not involved in the catalytic process. In the first 30 amino 
acids six consecutive not-charge residues are located at position 8-14 (GSIIISV), which could 
be a key area for integration into the membrane or surfactant – assuming the integration 
mechanism is similar to RPE65.79 
 
In additional to the N-terminus, AtCCD1 has a hydrophobic patch (chapter 4.1.1). All of the 
observed 13 amino acid mutations are outside of A41 to V194. In between these residues all 
three loops are located, that form the hydrophobic patch. 153 amino acids representing 
28.4 % of the protein where never mutated and selected after screening, emphasizing a 
negative selection pressure on most of these amino acids. Additionally enzymatic activity 
was compromised when residues 131, 146 + 149, 162 + 163 and 295 + 297 were mutated to 
remove exposed hydrophobic residues. 
CD 
In section 4.8.3, circular-dichroism (CD)-measurements of AtCCD1 are described. From the 
results, it can be seen that the organic solvent affects the distribution of α-helices and β-
sheets. Low concentrations of ethanol or 2-propanol have no visible effect on the absorption 
curves, whereas for higher concentrations independent of the deconvolution, strong effects 
on AtCCD1 can be seen. These changes are not necessarily reflected in the data after 
deconvolution, as the K2D algorithm and the absorption are not directly linked but reflect a 
similarity pattern to the reference protein database. Triton X-100 and protein concentration 
were the same for all samples. Triton is regularly used for CD measurements and is not 
known to interfere with the method, even if used in micellar concentrations.80 
 
The CD measurements with 10 % TFE showed that, besides its common usage as organic 
solvent for modeling experiments, TFE has a strong destructive effect on the secondary 
structure of AtCCD1. These data were backed by experiments, where no activity could be 
obtained in the presence of 10 % TFE. Recent studies on Baeyer-Villiger mono-oxygenases 
came to similar fast deactivation when investigating the effect of TFE on the enzymatic 
activity.81 Tetra-fluoro-ethanol can therefore be concluded to have unfavorable effects on 
AtCCD1. The CD data indicate that this might be due to changes in the secondary structure 
fold of AtCCD1. 
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Modeling 
The recorded CD-spectra differ from the modeled and predicted data. These deviations may 
not only be accounted by experimental design, e.g. the missing first 39 amino acids in the 
swissmodel, nor by the lack of purity of CCD1. In conclusion, the models do not accurately 
represent the state of the enzyme, and further calculations or homology modeling efforts 
were not considered. The strongest indication was the difference in measured and calculated 
α-helices, which can be quite precisely determined using CD. CCD1 is barely soluble in pure 
water, but needs either lipids or surfactants for solubilization (section 5.4). Consideration of 
lipids or surfactants adds a further level of complexity to the simulation, which was not further 
pursued. It shall also be noted that the CD spectra can be misleading as they are affected by 
multiple factors, e.g. purity of the enzyme, decomposition of the enzyme and finally 
deconvolution by the algorithm. 
 
5.3 Surfactants and AtCCD1 
AtCCD1 in non micellar environment 
Performance of AtCCD1 in a non-micellar environment, i.e. the apocarotenoid homogenously 
dispersed in the buffer/solution and addition of AtCCD1 without surfactants, would be very 
interesting to achieve. With this setup the effect of organic solvents on the enzyme could be 
directly studied without the effect of micelles. Several attempts were made, e.g. usage of 
room-temperature-ionic-liquids (RTILs), transformation in 100 % THF, DMSO, hexane or 
usage of cyclodextrines that allow a molecular solvation of the substrate – but no conversion 
was observed. To obtain activity or keeping the substrate in solution, the investigated 
aqueous buffer and solvent combinations always required surfactants or lipids. All 
experiments performed, indicate that AtCCD1 requires surfactants or lipids in order to be 
activated, i.e. a membrane bound or mimicked environment by surfactants is essential for 
enzymatic conversion. 
 
The effect of enzymatic activity could only be measured with the usage of micelles, 
liposomes (data not shown) or in vivo using membranes or lipids. Enzymatic activity without 
one of these co-solvents cannot be determined and therefore the effect of mutations and 
impact to micelle-interface or enzyme not be investigated separately.  
AtCCD1 in micellar environments 
Besides the lack of activity described above, AtCCD1 also requires surfactants for 
solubilization, e.g. Triton X-100 or lipids in vivo. The tag-free purification method (chapter 
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3.2.2) developed during this research is based on the lack of solubility of AtCCD1 in the 
absence of surfactants.  
 
Addition of surfactants adds a 
further level of complexity, e.g. 
protein concentrations cannot 
be determined directly, because 
the surfactants interfere with 
most detections assays (see 
chapter 4.9). More important, 
any in vitro measurement 
cannot exclude micelle 
formation due to remaining 
surfactants from the purification 
process. Even if the substrate is 
dissolved directly in an organic 
solvent e.g. DMSO, surfactants 
carry-over may be involved in 
the observed enzymatic 
conversion. Recent studies on RPE6579, a CCD related enzyme in bovines suggest that even 
the lipid-composition of the membrane is essential for the function of RPE65. The model that 
shows RPE65 sitting on a membrane may also explain why AtCCD1 needs a membrane or 
surfactant to be solubilized and functional, because the membrane is part of the protein. 
 
Further investigation is needed to address the arrangement of AtCCD1 with the involved 
lipids or surfactants on a molecular level. Particular the effects of organic solvents on the 
micelle structure are unknown (see section 2.3). 
 
5.4 CCD1 and organic solvents 
Prior to this research, one publication described the activation effect on AtCCD1 by organic 
solvents45. A correlation between the observed activation by organic solvent and its logP was 
drawn, however the impact of enzyme structure, hydration state or surfactant interface were 
not investigated. A year later a second publication showed that the choice of surfactants 
indeed influences the activity and the observed lag phase was investigated46. The effect of 
organic solvents on AtCCD1 and the different surfactants is essential for the evolution of 
enzymatic activity in organic solvents. Only if effects of organic solvents on surfactant and 
 
Figure 30: RPE65 attached to a phosphatidylcholine bilayer.  Putative 
membrane-anchoring residues are colored red, the central iron is 
represented as a brown sphere. Figure taken from
79
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protein can be monitored independently, conclusions and predictions that extend beyond the 
investigated examples may be drawn. 
 
For this thesis, effects of ethanol, 2-propanol and DMSO were investigated, activation and 
inhibition concentrations quantified and applied to engineer AtCCD1 towards improved 
organic solvent stability. The applied assay has been described for activity utilization by 
AtCCD19, it was adopted and successfully combines with a 96 well micro-titer-plate 
expression for the first time. Additionally it has been extended by a pretreatment, where the 
protein is subject to the stringent exposure to organic solvent and consecutively diluted to 
enable application of the micellar conversion system. The application of organic solvents is 
complex due to the effects described here and in chapter 2.3. For future applications it would 
be of great advantage to understand and separate the impact of organic solvents on enzyme 
and micelle, which is discussed in the following paragraph. 
Can the effect of solvent impact on enzyme and on micelles be separated? 
The pre-incubation assay was developed to separate the two coupled systems. During pre-
incubation only the enzyme (with little surfactant) is exposed to ethanol, then the sample is 
diluted and more surfactant including the substrate added. Therefore a lower concentration 
of ethanol affects the micelles and enzyme. From Figure 17 it can be seen that still both 
effects occur and that they overlap. On one hand the activation of the enzyme/micelle system 
is observed, which has its peak at 10 % (v/v) ethanol – independent of the pretreatment. On 
the other hand, the enzyme is less active if incubated with ethanol – proving an irreversible 
inhibition of AtCCD1 by exposure to ethanol. A significant drop in enzymatic activity was 
observed, if the ethanol concentration exceeds 30 % (v/v) for 45 minutes. This indicates that 
ethanol – and most likely other organic solvents – destabilize and deactivate AtCCD1, but 
performance in the micelle system is improved at low concentrations. Additional, long term 
exposure with low concentrations (15 %, v/v) of ethanol reduced enzymatic activity 
significantly as described in section 4.8.2. In conclusion,  the effect of organic solvents on 
micelles and on AtCCD1 cannot be uncoupled completely today. We can only assume that 
actually not AtCCD1 is activated by organic solvents, but instead the enzyme-substrate 
mediation in the micellar setup is enhanced. 
Can AtCCD1 be engineered towards improved activity in the presence of a 
particular surfactant? 
Implying that AtCCD1 cannot be active without surfactant or membrane (see above) and 
knowing that the membrane composition is important for activity of CCD similar proteins79, 
the idea of a surfactant tailored CCD is fundamental. Considering that ethanol compromises 
AtCCD1 activity even in lower concentrations (see above), a promising aspect for application 
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could be the development of AtCCD1 towards a particular substrate and surfactant 
combination. 
 
Experimentally, the used surfactants were chosen on performance and stability investigation 
of the substrate micelles by the project partner at the Karl-Winnacker-Institut in Frankfurt64. 
These led to two different systems, Triton X-100 for apo-8’-retinal assays and Tween 40 for 
carotenoid assays (zeaxanthin, β-carotene). The substrate and surfactant combinations are 
optimized for the applied conditions and changing them will require further fine-tuning, as e.g. 
zeaxanthin can be dissolved in Triton X-100 but is not stable and usually precipitates before 
the end of the measurement. If two structurally different surfactants that form stable micelles 
with a CCD1 substrate are selected, directed evolution towards each surfactant can be 
performed. In the optimal case, opposite effects as described here for 363G or 363T are 
observed and would demonstrate that CCD1 can be engineered towards different 
surfactants. This interesting topic opens up a new field of science and application that may 
extend well beyond the class of carotenoid cleavage dioxygenases. 
 
5.5 Carotenoid conversion by CCD1 
AtCCD1 is assumed to work only on apo-carotenoids in nature (see chapter 2.2), though in-
vivo and in-vitro experiments with recombinantly expressed AtCCD1 show, that β-carotene 
and further carotenoids are accepted as substrate71. Therefore conversion of β-carotene, 
zeaxanthin and astaxanthin was further investigated. β-carotene is an inexpensive 
carotenoid widely distributed and used in nature and industry. The challenge for β-carotene 
is the extreme hydrophobicity which renders it hardly available for enzymatic reactions. In 
vivo this is compensated by exposition in the membrane, so even small quantities can be 
easily detected. In vitro activities for β-carotene are usually dependent on extremely sensitive 
detection methods e.g. gas chromatography–mass spectrometry (GC-MS). In zeaxanthin 
and astaxanthin the oxygen renders the carotenoids less hydrophobic (predicted82 logP are 
14.95 and 13.27 respectively), which leads to exposure of the molecules on the surfactant-
water interface83 and therefore renders them available for enzymatic reactions. Ultimately 
zeaxanthin was chosen, as it is more stable and closer reassembles the properties of β-
carotene than astaxanthin.  
Activity determination by product fluorescence (C14) 
The idea of the assay was to describe AtCCD1 activity depending on the observed 
fluorescence that develops after conversion. Fluorescence correlated with CCD1 has been 
described before as side effect.11 A delay of the fluorescence by several hours to cleavage of 
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the substrate zeaxanthin was noticed experimentally; cleavage was monitored by complete 
bleaching of the solution, whereas fluorescence developed after the bleaching (Figure 21). 
The substance that caused the fluorescence proved to be very hydrophilic and could not be 
removed by organic solvent extraction, e.g. chloroform.  This distinguishes the C14 product 
from other cleavage products, e.g. the C17-dialdehyde, which accumulates in the organic 
phase when extracted with chloroform.  
 
Fluorescence may be caused by the formation of rosafluin84, the dialcohol of the central C14–
dialdehyde. Alternatively to the diol formation, an oxidation to the carboxylic acid could occur. 
It would be interesting to shift the rate limiting step from fluorescence development towards 
the CCD1 mediated cleavage reaction, ideally under physiological conditions, so that the 
enzymatic activity can be monitored in real-time. If this is achieved, the system will be unique 
and can detect cleavage of CCD1, independent of the provided substrate and its 
characteristics. Further CCD activity, e.g. 7-8 and 7’-8’ cleavage may also result in similar 
fluorescent products, as analysis of crocetindialdehyde implies69. 
 
Besides the observed delay, fluorescence and CCD1 activity are directly related and were 
used successfully for screening. Parallel screening for fluorescence and zeaxanthin depletion 
resulted in selection of the same variants, proving the feasibility of both assays. 
Zeaxanthin depletion 
The substrate depletion assay based on zeaxanthin is analogous to the apo-8’-retinal 
system9, but has not been described before. Specific absorption of two wavelengths were 
determined and used to monitor conversion. Compared to the fluorescence assay, the 
substrate depletion depends on the absorbance characteristics of the substrate and must be 
adjusted to each utilized substrate or product combination. For the 9-10 (9’-10’) cleavage of 
zeaxanthin the application is straight forward due to the substrate solution showing a strong 
yellow color whereas the cleaved products are transparent. 
 
5.6 Iterative rounds of evolution: Organic stability 
In the first round of mutagenesis, two transitions leading to amino acid changes were found. 
Both are, as expected, transition changes (T->C or A->G). Judging the ratio of activity 
between no supplementary ethanol and screening conditions (21.4% ethanol), S363G is the 
superior mutation on the amino-acid level. I10V is more likely an expression mutant, 
especially if considered in the combination with the mutation five nucleotides  upstream of 
the translation start. In the second round (ep-library 2), all selected mutants contained the 
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S363G mutation, supporting the importance of this residue. A combination of I10V and 
S363G was found (L2P11C5), which contains the two mutations of L1P1E2 indicating that it 
is a descendant of this mutant, but acquired 4-5 more mutations – one possibly from the 
other supplied mutant L1P3C9. The fact that none of the additional mutations found here 
were observed in any later rounds suggests that they are not beneficial and dead freight for 
AtCCD1 activity. The second improved variant (L2P22A12) showed two new mutations, one 
with an amino acid change of the first stop-codon (TAA) to a new amino acid (Q539). 
Extending the protein is not known to affect the stability; however increased stability against 
C-terminal degeneration might be an explanation. The mutational load in this library was 
rather high, which can be seen in the frequency of mutations found as well as the low activity 
ratio – the latter was compensated by screening 22 plates. In round three (ep-library 3) the 
known mutant S363G-Q539 was selected twice, so were two new mutants I10V-S363G 
(L3P2F5 and L3P7A6) and the closely related L3P6D5. It remains unknown if these 
mutations occurred independently or if they are recombinants of the provided template, both 
routes are possible. A new change on the amino acid level was M1-S264G-S363G which 
showed a changed start-codon (GTG instead of ATG) and a new glycine substitution at 
position S264. According to MAP54, transversions and C->T transitions should occure 
frequently with the applied method, conversely no transversion was observed and only one 
C->T transitions occurred (mutants L3P2F5 and L3P7A6).  
 
In the first SeSaM library (ep-library 4), a recombination of mutants (I10V-S363G and M1-
S264G-S363G) occurred; the former providing the first part of the gene, the latter 
contributing the second part of AtCCD1. This can be clearly concluded by the multiple 
inherited, partially silent mutations. The known mutant of S363G-Q539 (round 2+3) gained a 
characteristic SeSaM mutation (transversion followed by transition) leading to a triple mutant 
S363G-T536G-Q539. It can also be conclueded that the mutation was introduced from the 
G-reverse library, indicating that the dGTPαs occurred shortly after start of the PCR (original 
fragment size: 51nt). This supports the assumption that the distribution of SeSaM fragments 
was rather short and therefore led to the high mutational load and the observed low activity 
ratio of 3.5 %. The library was not extended beyond (360 clones) due to the low activity ratio. 
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5.7 Summary & Outlook 
Main achievements: 
Expression of AtCCD1 was downscaled and standardized in 96 well micro-titer-plates. Novel 
high-throughput activity determining assays for AtCCD1 were developed for 96 well plates, 
one for apo-8’-retinal conversion in presence of organic solvents (DMSO and ethyl-alcohol) 
and two for zeaxanthin conversion (one based on fluorescence, one on absorbance). Further 
a fast and reliable method for validation and quantification of cleavage products using 
reverse-phase TLC plates was developed and evaluated. Direct characterization of purified 
AtCCD1 was enabled by the one-step, tag-free purification protocol. 
 
AtCCD1 key-mutations for stability towards organic solvents (e.g. S363G) were determined 
as well as residues (S9, I10, S24, A41), which are involved in the putative surfactant/enzyme 
interface. Over five iterative rounds of evolution, the remaining AtCCD1 activity of ~20% after 
exposure was raised from 4.5 M to over 6 M ethyl alcohol (Figure 23). Further residues with 
impact on substrate selectivity and stability were identified. However, the impact of each 
individual residue requires further investigation. 
Impact on the research field 
Stability of dioxygenases towards organic solvents can be improved which was shown for 
ethyl alcohol and DMSO. Additionally the substrate specificity may be altered, which was 
shown for zeaxanthin. In contrast to the increase in activity of AtCCD1 by addition of organic 
solvents in micelles, this benefit was not observed for CCD1 cleavage of zeaxanthin. The low 
activity of AtCCD1 towards β-carotene is presumably a substrate delivery issue, particularly 
in micelles. It might be solved by investigation and engineering of the delivery system 
followed by enzyme engineering. 
Industrial application of dioxygenases 
Dioxgenases can be recombinantly expressed and tailored towards selected properties, e.g. 
substrates. Based on current knowledge, an industrial application utilizing either organic 
solvents or surfactants is anticipated. Application of particular surfactants and a specifically 
tailored CCD seems promising and feasible, whereas significant activity of CCDs in organic 
solvents without surfactants is not expected. To current knowledge a membrane mimicking 
environment is essential and cannot be achieved in pure or aqueous mixtures of organic 
solvents. Eventually this environment can be feigned by immobilization of the enzyme. 
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Outlook 
Enhanced tools are needed to characterize micellar systems on the molecular level. 
Currently available techniques are not able to answer essential questions e.g. how 
carotenoids are distributed in a micelle. Structure wise, crystals of membrane associated 
enzymes are rare, and current modeling approaches cannot consider membrane effects on 
the protein-fold. Structure details, especially of the CCD-surfactant interface are needed for a 
systematic description and comprehension of the substrate delivery in the micelles. Tailoring 
CCDs towards a specific substrate/surfactant combination is a novel idea, which is 
challenging and highly rewarding at once. 
 
For AtCCD1, the influence of selected residues needs further investigation to determine their 
individual contribution. Two approaches that might help characterizing AtCCD1 are extraction 
of AtCCD1 with Eupergit or PBA-EupergitT and quantification based on fluorescence of the 
C17-cleavage-product. Additionally the structure of the fluorescent C14-cleavage product has 
to be elucidated. 
 
 
                                               
T
  PBA-Eupergit = phenylbutylamin-Eupergit, a polymer that is used to immobilize enzymes by means 
of hydrophobic interactions. 
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6.2 List of primers 
                                               
I
   5’-Nco1-CCD1:  ATATGGCCATGGCGGAAAAACTGTCTG 
II
  3’-Hind3-CCd1:  GGCCGCAAGCTTTTATTAAATCAGGGTCTG 
III
  BamH1-Nco1-5’: TGGGATCCATGGCGGAAAAACTGTCTG 
IV
  CCD1-xho1-3’: GCAAGCTTCTCGAGTTATTAAATCAGGGTCTG 
V
  CCD1-delta-16:  ATGGATCCCGTCCGAGCAAAGGCTTTAGC 
VI
  CCD1-delta-39: AGGGATCCGATGCGAGCCTGCCG 
VII
  CCD1-delta-55: ATGGATCCCGTGATGAAACCCCGCC 
VIII
  F1:   CGACTCACTATAGGGGAATTGTGAGCGGA 
IX
  R3:   CGGGCTTTGTTAGCAGCCGGATCTCAG 
X
  R4:   GCAAAAAACCCCTCAAGACCCGTTTAGA 
XI
  F1-Up:  CGCCTGTCACCGACTCACTATAGGGGAATTGTGAGCGGA 
XII
  R4-down:   GCGGACAGTGGCAAAAAACCCCTCAAGACCCGTTTAGA 
XIII
  DB_SS10_F2:  CTGTCTGATGGCAGCNNKATTATTAGCGTGCATC 
XIV
  DB_SS10_R2:  GATGCACGCTAATAATMNNGCTGCCATCAGACAG 
XV
  DB_SS194_F:  CGGATAAACCGTACNNKATTAAAGTGCTGGAAG 
XVI
  DB_SS194_R:  CTTCCAGCACTTTAATMNNGTACGGTTTATCCG 
XVII
  DB_SS264_F: GTGCCGATTACCATTNNKGAACCGATCATGATGC 
XVIII
  DB_SS264_R: GCATCATGATCGGTTCMNNAATGGTAATCGGCAC 
XIX
  DB-CCD1SS363F: GGATCTGGATATGGTGNNNGGCAAAGTTAAAGAAAAACTG 
XX
  DB-CCD1SS363r: CAGTTTTTCTTTAACTTTGCCNNNCACCATATCCAGATCC 
XXI
  DB_SS397_F: CCAGAAAAAACTGAGCGCGNNKGCGGTGGATTTTCCG 
XXII
  DB_SS397_R: CGGAAAATCCACCGCMNNCGCGCTCAGTTTTTTCTGG 
